Literatures

Primary Site >> Liver Cancer

Gene >> GPC3

1.
Journal:
Title:	Simpson-Golabi-Behmel Syndrome Type 1
Author:	Golabi, Mahin\|Leung, Alva\|Lopez, Christina
PMID:	20301398

2.
Journal:	Cancer Res. 1997 Nov 15;57(22):5179-84.
Title:	Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Author:	Hsu, H C\|Cheng, W\|Lai, P L
PMID:	9371521

3.
Journal:	J Med Genet. 1998 Feb;35(2):153-6.
Title:	A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma.
Author:	Lapunzina, P\|Badia, I\|Galoppo, C\|De Matteo, E\|Silberman, P\|Tello, A\|Grichener, J\|Hughes-Benzie, R
PMID:	9507397

4.
Journal:	Zhonghua Wai Ke Za Zhi. 1999 Mar;37(3):171-3, 10.
Title:	[Expression and significance of MXR7 mRNA in human hepatocellular carcinoma].
Author:	Zhou, X\|Wang, H\|Yang, G\|Chen, Z\|Li, B\|Wu, M
PMID:	11829813

5.
Journal:	World J Gastroenterol. 2000 Feb;6(1):57-60.
Title:	Cloning and expression of MXR7 gene in human HCC tissue.
Author:	Zhou, Xue-Ping\|Wang, Hong-Yang\|Yang, Guang-Shun\|Chen, Zheng-Jun\|Li, Bao-An\|Wu, Meng-Chao
PMID:	11819523

6.
Journal:	Int J Cancer. 2003 Feb 10;103(4):455-65.
Title:	Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Author:	Midorikawa, Yutaka\|Ishikawa, Shumpei\|Iwanari, Hiroko\|Imamura, Takeshi\|Sakamoto, Hirohiko\|Miyazono, Kohei\|Kodama, Tatsuhiko\|Makuuchi, Masatoshi\|Aburatani, Hiroyuki
PMID:	12478660

7.
Journal:	Cancer Sci. 2003 Mar;94(3):259-62.
Title:	Glypican-3 is overexpressed in human hepatocellular carcinoma.
Author:	Sung, Young Kwan\|Hwang, Sun Young\|Park, Mi Kyung\|Farooq, Mohammad\|Han, In Sook\|Bae, Han Ik\|Kim, Jung-Chul\|Kim, Moonkyu
PMID:	12824919

8.
Journal:	Gastroenterology. 2003 Jul;125(1):89-97.
Title:	Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.
Author:	Capurro, Mariana\|Wanless, Ian R\|Sherman, Morris\|Deboer, Gerrit\|Shi, Wen\|Miyoshi, Eiji\|Filmus, Jorge
PMID:	12851874

9.
Journal:	Exp Mol Med. 2003 Aug 31;35(4):257-62.
Title:	Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.
Author:	Sung, Young Kwan\|Hwang, Sung Young\|Farooq, Mohammad\|Kim, Jung-Chul\|Kim, Moon Kyu
PMID:	14508064

10.
Journal:	Biochem Biophys Res Commun. 2004 Mar 19;315(4):950-8.
Title:	Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma.
Author:	Huang, Jhy-Shrian\|Chao, Chuan-Chuan\|Su, Teh-Li\|Yeh, Shiou-Hwei\|Chen, Ding-Shinn\|Chen, Chiung-Tong\|Chen, Pei-Jer\|Jou, Yuh-Shan
PMID:	14985104

11.
Journal:	Cancer Res. 2004 Apr 1;64(7):2418-23.
Title:	Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Author:	Hippo, Yoshitaka\|Watanabe, Kiyotaka\|Watanabe, Akira\|Midorikawa, Yutaka\|Yamamoto, Shogo\|Ihara, Sigeo\|Tokita, Susumu\|Iwanari, Hiroko\|Ito, Yukio\|Nakano, Kiyotaka\|Nezu, Jun-ichi\|Tsunoda, Hiroyuki\|Yoshino, Takeshi\|Ohizumi, Iwao\|Tsuchiya, Masayuki\|Ohnishi, Shin
PMID:	15059894

12.
Journal:	Clin Cancer Res. 2004 Oct 1;10(19):6612-21.
Title:	Identification of glypican-3 as a novel tumor marker for melanoma.
Author:	Nakatsura, Tetsuya\|Kageshita, Toshiro\|Ito, Shosuke\|Wakamatsu, Kazumasa\|Monji, Mikio\|Ikuta, Yoshiaki\|Senju, Satoru\|Ono, Tomomichi\|Nishimura, Yasuharu
PMID:	15475451

13.
Journal:	Clin Cancer Res. 2004 Dec 15;10(24):8630-40.
Title:	Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
Author:	Nakatsura, Tetsuya\|Komori, Hiroyuki\|Kubo, Tatsuko\|Yoshitake, Yoshihiro\|Senju, Satoru\|Katagiri, Toyomasa\|Furukawa, Yoichi\|Ogawa, Michio\|Nakamura, Yusuke\|Nishimura, Yasuharu
PMID:	15623647

14.
Journal:	Mol Diagn. 2004;8(4):207-12.
Title:	Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.
Author:	Filmus, Jorge\|Capurro, Mariana
PMID:	15887976

15.
Journal:	Oncogene. 2005 May 26;24(23):3737-47.
Title:	An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma.
Author:	Patil, Mohini A\|Chua, Mei-Sze\|Pan, Kuang-Hung\|Lin, Richard\|Lih, Chih-Jian\|Cheung, Siu-Tim\|Ho, Coral\|Li, Rui\|Fan, Sheung-Tat\|Cohen, Stanley N\|Chen, Xin\|So, Samuel
PMID:	15735714

16.
Journal:	BMC Bioinformatics. 2005 Apr 13;6:97.
Title:	Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.
Author:	Grate, Leslie R
PMID:	15826317

17.
Journal:	J Gastroenterol. 2005 Mar;40 Suppl 16:1-6.
Title:	Discovery of a new biomarker for gastroenterological cancers.
Author:	Aburatani, Hiroyuki
PMID:	15902956

18.
Journal:	Mod Pathol. 2005 Dec;18(12):1591-8.
Title:	The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
Author:	Yamauchi, Naoko\|Watanabe, Akira\|Hishinuma, Michiyo\|Ohashi, Ken-Ichi\|Midorikawa, Yutaka\|Morishita, Yasuyuki\|Niki, Toshiro\|Shibahara, Junji\|Mori, Masaya\|Makuuchi, Masatoshi\|Hippo, Yoshitaka\|Kodama, Tatsuhiko\|Iwanari, Hiroko\|Aburatani, Hiroyuki\|Fukayama, Mas
PMID:	15920546

19.
Journal:	World J Gastroenterol. 2005 Jul 7;11(25):3850-4.
Title:	Expression and significance of tumor-related genes in HCC.
Author:	Lu, Zi-Li\|Luo, Dian-Zhong\|Wen, Jian-Ming
PMID:	15991281

20.
Journal:	Cancer Res. 2005 Jul 15;65(14):6245-54.
Title:	Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
Author:	Capurro, Mariana I\|Xiang, Yun-Yan\|Lobe, Corrinne\|Filmus, Jorge
PMID:	16024626

21.
Journal:	Liver Int. 2005 Oct;25(5):962-6.
Title:	Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.
Author:	Man, Xiao-Bo\|Tang, Liang\|Zhang, Bao-Hua\|Li, Shen-Jing\|Qiu, Xiu-Hua\|Wu, Meng-Chao\|Wang, Hong-Yang
PMID:	16162153

22.
Journal:	J Biol Chem. 2005 Dec 16;280(50):41201-6.
Title:	Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.
Author:	Capurro, Mariana I\|Shi, Wen\|Sandal, Shaifali\|Filmus, Jorge
PMID:	16227623

23.
Journal:	Clin Biochem Rev. 2005 Aug;26(3):65-79.
Title:	Recent developments in the first detection of hepatocellular carcinoma.
Author:	Lopez, Joseph B
PMID:	16450014

24.
Journal:	Cancer Res. 2006 Feb 15;66(4):2414-22.
Title:	Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
Author:	Motomura, Yutaka\|Senju, Satoru\|Nakatsura, Tetsuya\|Matsuyoshi, Hidetake\|Hirata, Shinya\|Monji, Mikio\|Komori, Hiroyuki\|Fukuma, Daiki\|Baba, Hideo\|Nishimura, Yasuharu
PMID:	16489048

25.
Journal:	Clin Cancer Res. 2006 May 1;12(9):2689-97.
Title:	Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
Author:	Komori, Hiroyuki\|Nakatsura, Tetsuya\|Senju, Satoru\|Yoshitake, Yoshihiro\|Motomura, Yutaka\|Ikuta, Yoshiaki\|Fukuma, Daiki\|Yokomine, Kazunori\|Harao, Michiko\|Beppu, Toru\|Matsui, Masanori\|Torigoe, Toshihiko\|Sato, Noriyuki\|Baba, Hideo\|Nishimura, Yasuharu
PMID:	16675560

26.
Journal:	Mol Cells. 2006 Apr 30;21(2):224-8.
Title:	Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
Author:	Kwack, Mi Hee\|Choi, Byung Yeol\|Sung, Young Kwan
PMID:	16682817

27.
Journal:	Hepatobiliary Pancreat Dis Int. 2006 May;5(2):257-61.
Title:	Gradual upregulation of OCI-5 expression during occurrence and progression of rat hepatocellular carcinoma.
Author:	Jiang, Wei-Jun\|Man, Xiao-Bo\|Tang, Liang\|Song, Hong-Yin\|Li, Shen-Jing\|Cai, Guo-Jun\|Qiu, Xiu-Hua\|Hu, He-Ping
PMID:	16698587

28.
Journal:	Zhonghua Wai Ke Za Zhi. 2006 Apr 1;44(7):458-62.
Title:	[Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Author:	Li, Bao-ding\|Zhao, Qing-chuan\|Zhu, Yang-ting\|Zhang, Fu-qin\|Dou, Ke-feng
PMID:	16772080

29.
Journal:	Am J Surg Pathol. 2006 Nov;30(11):1405-11.
Title:	Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Author:	Libbrecht, Louis\|Severi, Tamara\|Cassiman, David\|Vander Borght, Sara\|Pirenne, Jacques\|Nevens, Frederik\|Verslype, Chris\|van Pelt, Jos\|Roskams, Tania
PMID:	17063081

30.
Journal:	Gastroenterology. 2006 Dec;131(6):1758-67.
Title:	A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Author:	Llovet, Josep M\|Chen, Yingbei\|Wurmbach, Elisa\|Roayaie, Sasan\|Fiel, M Isabel\|Schwartz, Myron\|Thung, Swan N\|Khitrov, Gregory\|Zhang, Weijia\|Villanueva, Augusto\|Battiston, Carlo\|Mazzaferro, Vincenzo\|Bruix, Jordi\|Waxman, Samuel\|Friedman, Scott L
PMID:	17087938

31.
Journal:	Lab Invest. 2006 Dec;86(12):1272-84.
Title:	The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells.
Author:	Grozdanov, Petar N\|Yovchev, Mladen I\|Dabeva, Mariana D
PMID:	17117158

32.
Journal:	Gan To Kagaku Ryoho. 2006 Nov;33(12):1742-4.
Title:	[Possibilities of glypican-3-specific immunotherapy for hepatocellular carcinoma].
Author:	Komori, Hiroyuki\|Nakatsura, Tetsuya\|Beppu, Toru\|Nishimura, Yasuharu\|Baba, Hideo
PMID:	17212093

33.
Journal:	Clin Cancer Res. 2007 Feb 15;13(4):1133-9.
Title:	Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
Author:	Jia, Hu-Liang\|Ye, Qing-Hai\|Qin, Lun-Xiu\|Budhu, Anuradha\|Forgues, Marshonna\|Chen, Yidong\|Liu, Yin-Kun\|Sun, Hui-Chuan\|Wang, Lu\|Lu, Hong-Zhou\|Shen, Fang\|Tang, Zhao-You\|Wang, Xin Wei
PMID:	17317821

34.
Journal:	Hepatology. 2007 Nov;46(5):1541-7.
Title:	The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2.
Author:	Morford, Lorri A\|Davis, Christina\|Jin, Lin\|Dobierzewska, Aneta\|Peterson, Martha L\|Spear, Brett T
PMID:	17668883

35.
Journal:	Cancer. 2007 Oct 25;111(5):316-22.
Title:	Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
Author:	Kandil, Dina\|Leiman, Gladwyn\|Allegretta, Mark\|Trotman, Winifred\|Pantanowitz, Liron\|Goulart, Robert\|Evans, Mark
PMID:	17763368

36.
Journal:	Mod Pathol. 2008 May;21(5):626-31.
Title:	Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study.
Author:	Ligato, Saverio\|Mandich, Daniza\|Cartun, Richard W
PMID:	18264086

37.
Journal:	Am J Surg Pathol. 2008 Mar;32(3):433-44.
Title:	Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Author:	Coston, Wanda M P\|Loera, Sofia\|Lau, Sean K\|Ishizawa, Shin\|Jiang, Zhong\|Wu, Chin-Lee\|Yen, Yun\|Weiss, Lawrence M\|Chu, Peiguo G
PMID:	18300806

38.
Journal:	Hepatology. 2008 Apr;47(4):1211-22.
Title:	Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Author:	Lai, Jin-Ping\|Sandhu, Dalbir S\|Yu, Chunrong\|Han, Tao\|Moser, Catherine D\|Jackson, Kenard K\|Guerrero, Ruben Bonilla\|Aderca, Ileana\|Isomoto, Hajime\|Garrity-Park, Megan M\|Zou, Hongzhi\|Shire, Abdirashid M\|Nagorney, David M\|Sanderson, Schuyler O\|Adjei, Alex A\|L
PMID:	18318435

39.
Journal:	Eur J Cancer. 2008 Apr;44(6):885-97.
Title:	Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data.
Author:	Kittaka, Nobuyoshi\|Takemasa, Ichiro\|Takeda, Yutaka\|Marubashi, Shigeru\|Nagano, Hiroaki\|Umeshita, Koji\|Dono, Keizo\|Matsubara, Kenichi\|Matsuura, Nariaki\|Monden, Morito
PMID:	18337085

40.
Journal:	Carcinogenesis. 2008 Jul;29(7):1319-26.
Title:	Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
Author:	Cheng, Wei\|Tseng, Chia-Jen\|Lin, Tom T C\|Cheng, I\|Pan, Hung-Wei\|Hsu, Hey-Chi\|Lee, Yu-May
PMID:	18413366

41.
Journal:	Int J Oncol. 2008 May;32(5):985-90.
Title:	HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice.
Author:	Motomura, Yutaka\|Ikuta, Yoshiaki\|Kuronuma, Toshimitsu\|Komori, Hiroyuki\|Ito, Masaaki\|Tsuchihara, Masami\|Tsunoda, Yoshiyuki\|Shirakawa, Hirofumi\|Baba, Hideo\|Nishimura, Yasuharu\|Kinoshita, Taira\|Nakatsura, Tetsuya
PMID:	18425324

42.
Journal:	Am J Clin Pathol. 2008 Jun;129(6):899-906.
Title:	Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples.
Author:	Baumhoer, Daniel\|Tornillo, Luigi\|Stadlmann, Sylvia\|Roncalli, Massimo\|Diamantis, Eva Karamitopoulou\|Terracciano, Luigi M
PMID:	18480006

43.
Journal:	Am J Clin Pathol. 2008 Aug;130(2):219-23.
Title:	Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
Author:	Anatelli, Florencia\|Chuang, Shang-Tian\|Yang, Ximing J\|Wang, Hanlin L
PMID:	18628090

44.
Journal:	Pol J Pathol. 2008;59(1):15-20.
Title:	Glypican-3 is expressed in chromophobe renal cell carcinomas.
Author:	Okon, Krzysztof
PMID:	18655366

45.
Journal:	Nihon Rinsho Meneki Gakkai Kaishi. 2008 Oct;31(5):383-91.
Title:	[Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma].
Author:	Nishimura, Yasuharu\|Nakatsura, Tetsuya\|Senju, Satoru
PMID:	18974622

46.
Journal:	Arch Pathol Lab Med. 2008 Nov;132(11):1723-8.
Title:	Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Author:	Wang, Hanlin L\|Anatelli, Florencia\|Zhai, Qihui Jim\|Adley, Brian\|Chuang, Shang-Tian\|Yang, Ximing J
PMID:	18976006

47.
Journal:	Cancer Res. 2008 Dec 1;68(23):9832-8.
Title:	Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer.
Author:	Ishiguro, Takahiro\|Sugimoto, Masamichi\|Kinoshita, Yasuko\|Miyazaki, Yoko\|Nakano, Kiyotaka\|Tsunoda, Hiroyuki\|Sugo, Izumi\|Ohizumi, Iwao\|Aburatani, Hiroyuki\|Hamakubo, Takao\|Kodama, Tatsuhiko\|Tsuchiya, Masayuki\|Yamada-Okabe, Hisafumi
PMID:	19047163

48.
Journal:	Biochem Biophys Res Commun. 2009 Jan 9;378(2):279-84.
Title:	Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells.
Author:	Nakano, Kiyotaka\|Orita, Tetsuro\|Nezu, Junichi\|Yoshino, Takeshi\|Ohizumi, Iwao\|Sugimoto, Masamichi\|Furugaki, Koh\|Kinoshita, Yasuko\|Ishiguro, Takahiro\|Hamakubo, Takao\|Kodama, Tatsuhiko\|Aburatani, Hiroyuki\|Yamada-Okabe, Hisafumi\|Tsuchiya, Masayuki
PMID:	19022220

49.
Journal:	Liver Int. 2009 Aug;29(7):1056-64.
Title:	The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma.
Author:	Takai, Hirotake\|Kato, Atsuhiko\|Kato, Chie\|Watanabe, Takeshi\|Matsubara, Koichi\|Suzuki, Masami\|Kataoka, Hiroaki
PMID:	19141032

50.
Journal:	Int J Oncol. 2009 Mar;34(3):649-56.
Title:	Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
Author:	Shirakawa, Hirofumi\|Kuronuma, Toshimitsu\|Nishimura, Yoshiko\|Hasebe, Takahiro\|Nakano, Masayuki\|Gotohda, Naoto\|Takahashi, Shinichiro\|Nakagohri, Toshio\|Konishi, Masaru\|Kobayashi, Nobuaki\|Kinoshita, Taira\|Nakatsura, Tetsuya
PMID:	19212669

51.
Journal:	J Hepatol. 2009 Apr;50(4):746-54.
Title:	The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.
Author:	Di Tommaso, Luca\|Destro, Annarita\|Seok, Jae Yeon\|Balladore, Emanuela\|Terracciano, Luigi\|Sangiovanni, Angelo\|Iavarone, Massimo\|Colombo, Massimo\|Jang, Ja June\|Yu, Eunsil\|Jin, So Young\|Morenghi, Emanuela\|Park, Young Nyun\|Roncalli, Massimo
PMID:	19231003

52.
Journal:	Cancer Sci. 2009 Apr;100(4):626-32.
Title:	Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
Author:	Ushiku, Tetsuo\|Uozaki, Hiroshi\|Shinozaki, Aya\|Ota, Satoshi\|Matsuzaka, Keisuke\|Nomura, Sachiyo\|Kaminishi, Michio\|Aburatani, Hiroyuki\|Kodama, Tatsuhiko\|Fukayama, Masashi
PMID:	19243386

53.
Journal:	Cancer Biol Ther. 2009 May;8(10):930-8. Epub 2009 May 10.
Title:	Histopathological analyses of the antitumor activity of anti-glypican-3 antibody (GC33) in human liver cancer xenograft models: The contribution of macrophages.
Author:	Takai, Hirotake\|Kato, Atsuhiko\|Kinoshita, Yasuko\|Ishiguro, Takahiro\|Takai, Yayoi\|Ohtani, Yoshimi\|Sugimoto, Masamichi\|Suzuki, Masami
PMID:	19276671

54.
Journal:	Cancer Sci. 2009 Aug;100(8):1403-7.
Title:	Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma.
Author:	Shirakawa, Hirofumi\|Suzuki, Hitomi\|Shimomura, Manami\|Kojima, Motohiro\|Gotohda, Naoto\|Takahashi, Shinichiro\|Nakagohri, Toshio\|Konishi, Masaru\|Kobayashi, Nobuaki\|Kinoshita, Taira\|Nakatsura, Tetsuya
PMID:	19496787

55.
Journal:	Oncol Rep. 2009 Jul;22(1):149-54.
Title:	Detection of glypican-3-specific CTLs in chronic hepatitis and liver cirrhosis.
Author:	Hayashi, Emiko\|Motomura, Yutaka\|Shirakawa, Hirofumi\|Yoshikawa, Toshiaki\|Oba, Nobuyuki\|Nishinakagawa, Shuta\|Mizuguchi, Yasuhiro\|Kojima, Tatsuya\|Nomura, Kazuhiro\|Nakatsura, Tetsuya
PMID:	19513517

56.
Journal:	Cancer. 2009 Aug 25;117(4):271-8.
Title:	Glypican-3 protein expression in primary and metastatic melanoma: a combined immunohistochemistry and immunocytochemistry study.
Author:	Kandil, Dina\|Leiman, Gladwyn\|Allegretta, Mark\|Evans, Mark
PMID:	19517479

57.
Journal:	Adv Anat Pathol. 2009 Mar;16(2):125-9.
Title:	Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
Author:	Kandil, Dina H\|Cooper, Kumarasen
PMID:	19550373

58.
Journal:	Am J Pathol. 2009 Aug;175(2):717-24.
Title:	Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.
Author:	Liu, Bowen\|Paranjpe, Shirish\|Bowen, William C\|Bell, Aaron W\|Luo, Jian-Hua\|Yu, Yan-Ping\|Mars, Wendy M\|Michalopoulos, George K
PMID:	19574424

59.
Journal:	Cancer Biol Ther. 2009 Dec;8(24):2329-38. Epub 2009 Dec 3.
Title:	Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma.
Author:	Takai, Hirotake\|Ashihara, Motohki\|Ishiguro, Takahiro\|Terashima, Hiromichi\|Watanabe, Takeshi\|Kato, Atsuhiko\|Suzuki, Masami
PMID:	19838081

60.
Journal:	Acta Histochem. 2010 May;112(3):240-50.
Title:	Optimization of tissue processing for immunohistochemistry for the detection of human glypican-3.
Author:	Takai, Hirotake\|Kato, Atsuhiko\|Ishiguro, Takahiro\|Kinoshita, Yasuko\|Karasawa, Yayoi\|Otani, Yoshimi\|Sugimoto, Masamichi\|Suzuki, Masami\|Kataoka, Hiroaki
PMID:	19246079

61.
Journal:	J Gastroenterol Hepatol. 2010 Jan;25(1):129-37.
Title:	Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Author:	Tangkijvanich, Pisit\|Chanmee, Theerawut\|Komtong, Sanpoj\|Mahachai, Varocha\|Wisedopas, Naruemon\|Pothacharoen, Peraphan\|Kongtawelert, Prachya
PMID:	19793164

62.
Journal:	Int J Cancer. 2010 Mar 15;126(6):1291-301.
Title:	Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo.
Author:	Zittermann, Sandra I\|Capurro, Mariana I\|Shi, Wen\|Filmus, Jorge
PMID:	19816934

63.
Journal:	Am J Surg Pathol. 2010 Apr;34(4):533-40.
Title:	SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Author:	Ushiku, Tetsuo\|Shinozaki, Aya\|Shibahara, Junji\|Iwasaki, Yoshiaki\|Tateishi, Yoko\|Funata, Nobuaki\|Fukayama, Masashi
PMID:	20182341

64.
Journal:	Oncol Rep. 2010 May;23(5):1325-30.
Title:	Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
Author:	Saito, Yumi\|Oba, Nobuyuki\|Nishinakagawa, Syuta\|Mizuguchi, Yasuhiro\|Kojima, Tatsuya\|Nomura, Kazuhiro\|Nakatsura, Tetsuya
PMID:	20372847

65.
Journal:	Hepatol Res. 2010 May;40(5):477-85.
Title:	Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma.
Author:	Yasuda, Eisuke\|Kumada, Takashi\|Toyoda, Hidenori\|Kaneoka, Yuji\|Maeda, Atsuyuki\|Okuda, Seiji\|Yoshimi, Naoki\|Kozawa, Osamu
PMID:	20374302

66.
Journal:	Clin Biochem. 2010 Aug;43(12):1003-8.
Title:	Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma.
Author:	Zhang, Qianyun\|Xiao, Qin\|Lin, Zhen\|Ying, Xitang\|Li, Zhenjia\|Lin, Jin-Ming
PMID:	20444424

67.
Journal:	Int J Surg Pathol. 2010 Oct;18(5):313-8.
Title:	Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
Author:	Abdul-Al, Hala M\|Wang, Guanghua\|Makhlouf, Hala R\|Goodman, Zachary D
PMID:	20444731

68.
Journal:	J Clin Pathol. 2010 Jul;63(7):599-603.
Title:	Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
Author:	Wang, Feng Hua\|Yip, Yuk Ching\|Zhang, Meng\|Vong, Heong Ting\|Chan, Kin Iong\|Wai, Kit Cheng\|Wen, Jian Ming
PMID:	20501450

69.
Journal:	Jpn J Clin Oncol. 2010 Sep;40(9):891-6.
Title:	Molecular diagnosis of multistage hepatocarcinogenesis.
Author:	Sakamoto, Michiie\|Effendi, Kathryn\|Masugi, Yohei
PMID:	20603246

70.
Journal:	World J Gastroenterol. 2010 Jul 28;16(28):3521-8.
Title:	Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma.
Author:	Akutsu, Noriyuki\|Yamamoto, Hiroyuki\|Sasaki, Shigeru\|Taniguchi, Hiroaki\|Arimura, Yoshiaki\|Imai, Kohzoh\|Shinomura, Yasuhisa
PMID:	20653060

71.
Journal:	Hepatology. 2010 Nov;52(5):1680-9.
Title:	The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.
Author:	Lai, Jin-Ping\|Oseini, Abdul M\|Moser, Catherine D\|Yu, Chunrong\|Elsawa, Sherine F\|Hu, Chunling\|Nakamura, Ikuo\|Han, Tao\|Aderca, Ileana\|Isomoto, Hajime\|Garrity-Park, Megan M\|Shire, Abdirashid M\|Li, Jia\|Sanderson, Schuyler O\|Adjei, Alex A\|Fernandez-Zapico, Mar
PMID:	20725905

72.
Journal:	J Cell Biochem. 2010 Dec 1;111(5):1252-9.
Title:	Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells.
Author:	Cho, Hye-Sim\|Ahn, Jung-Mo\|Han, Ho-Jae\|Cho, Je-Yoel
PMID:	20803547

73.
Journal:	Hepatology. 2010 Sep;52(3):1060-7.
Title:	Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
Author:	Liu, Bowen\|Bell, Aaron W\|Paranjpe, Shirish\|Bowen, William C\|Khillan, Jaspal S\|Luo, Jian-Hua\|Mars, Wendy M\|Michalopoulos, George K
PMID:	20812357

74.
Journal:	World J Gastroenterol. 2010 Sep 21;16(35):4410-5.
Title:	Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma.
Author:	Liu, Hui\|Li, Peng\|Zhai, Yun\|Qu, Chun-Feng\|Zhang, Li-Jie\|Tan, Yu-Fen\|Li, Ning\|Ding, Hui-Guo
PMID:	20845507

75.
Journal:	Anticancer Drugs. 2010 Nov;21(10):907-16.
Title:	Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization.
Author:	Nakano, Kiyotaka\|Ishiguro, Takahiro\|Konishi, Hiroko\|Tanaka, Megumi\|Sugimoto, Masamichi\|Sugo, Izumi\|Igawa, Tomoyuki\|Tsunoda, Hiroyuki\|Kinoshita, Yasuko\|Habu, Kiyoshi\|Orita, Tetsuro\|Tsuchiya, Masayuki\|Hattori, Kunihiro\|Yamada-Okabe, Hisafumi
PMID:	20847643

76.
Journal:	Diagn Pathol. 2010 Sep 25;5:64.
Title:	Expression of glypican 3 in placental site trophoblastic tumor.
Author:	Ou-Yang, Robin J\|Hui, Pei\|Yang, Ximing J\|Zynger, Debra L
PMID:	20868507

77.
Journal:	Nihon Rinsho. 2010 Jul;68 Suppl 7:833-6.
Title:	[Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma].
Author:	Komori, Hiroyuki\|Beppu, Toru\|Baba, Hideo\|Nakatsura, Tetsuya\|Nishimura, Yasuharu
PMID:	20960882

78.
Journal:	Anticancer Res. 2010 Dec;30(12):5055-61.
Title:	Up-regulation of glypican-3 in human hepatocellular carcinoma.
Author:	Suzuki, Masahiro\|Sugimoto, Kazushi\|Tanaka, Junichiro\|Tameda, Masahiko\|Inagaki, Yuji\|Kusagawa, Satoko\|Nojiri, Keiichiro\|Beppu, Tetsuya\|Yoneda, Kentaro\|Yamamoto, Norihiko\|Ito, Masaaki\|Yoneda, Misao\|Uchida, Kazuhiko\|Takase, Koujiro\|Shiraki, Katsuya
PMID:	21187490

79.
Journal:	Liver Int. 2011 Jan;31(1):120-31.
Title:	Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma.
Author:	Yorita, Kenji\|Takahashi, Nobuyasu\|Takai, Hirotake\|Kato, Atsuhiko\|Suzuki, Masami\|Ishiguro, Takahiro\|Ohtomo, Toshihiko\|Nagaike, Koki\|Kondo, Kazuhiro\|Chijiiwa, Kazuo\|Kataoka, Hiroaki
PMID:	20964802

80.
Journal:	Pathol Res Pract. 2011 Jan 15;207(1):8-14.
Title:	Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
Author:	Longerich, Thomas\|Haller, Maria Theresia\|Mogler, Carolin\|Aulmann, Sebastian\|Lohmann, Volker\|Schirmacher, Peter\|Brand, Karsten
PMID:	20971570

81.
Journal:	Eur J Cancer. 2011 Feb;47(3):333-8.
Title:	Glypican-3: a new target for cancer immunotherapy.
Author:	Ho, Mitchell\|Kim, Heungnam
PMID:	21112773

82.
Journal:	Cancer Sci. 2011 May;102(5):918-25.
Title:	HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells.
Author:	Yoshikawa, Toshiaki\|Nakatsugawa, Munehide\|Suzuki, Shiro\|Shirakawa, Hirofumi\|Nobuoka, Daisuke\|Sakemura, Noriko\|Motomura, Yutaka\|Tanaka, Yukie\|Hayashi, Shin-Ichi\|Nakatsura, Tetsuya
PMID:	21281401

83.
Journal:	Mol Imaging. 2011 Feb;10(1):69-77.
Title:	Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles.
Author:	Park, James O\|Stephen, Zachary\|Sun, Conroy\|Veiseh, Omid\|Kievit, Forrest M\|Fang, Chen\|Leung, Matthew\|Mok, Hyejung\|Zhang, Miqin
PMID:	21303616

84.
Journal:	Gut. 2011 Jul;60(7):967-76.
Title:	EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Author:	Cai, Mu-Yan\|Tong, Zhu-Ting\|Zheng, Fang\|Liao, Yi-Ji\|Wang, Yi\|Rao, Hui-Lan\|Chen, Yang-Chao\|Wu, Qiu-Liang\|Liu, Yan-Hui\|Guan, Xin-Yuan\|Lin, Marie C\|Zeng, Yi-Xin\|Kung, Hsiang-Fu\|Xie, Dan
PMID:	21330577

85.
Journal:	Ann Diagn Pathol. 2011 Jun;15(3):162-9.
Title:	Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma.
Author:	Yan, Bin\|Wei, Jing-Jing\|Qian, Yi-Ming\|Zhao, Xiang-Li\|Zhang, Wei-Wei\|Xu, Ai-Min\|Zhang, Shu-Hui
PMID:	21371925

86.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2011 Jan;40(1):11-6.
Title:	[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
Author:	DU, Jing-li\|Wei, Li-xin\|Wang, Yu-lan
PMID:	21429352

87.
Journal:	BMC Cancer. 2011 Mar 28;11:111.
Title:	Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma.
Author:	Gong, Li\|Zheng, Minwen\|Li, Yanhong\|Zhang, Wendong\|Bu, Wangjun\|Shi, Lifang\|Zhang, Wei\|Yan, Hong
PMID:	21443783

88.
Journal:	Hepatobiliary Pancreat Dis Int. 2011 Apr;10(2):164-70.
Title:	GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma associated with hepatitis B virus.
Author:	Yang, Jun-Wen\|Yang, Dong-Ye\|Lu, Fang-Gen\|Li, Cai-Hong\|Chen, Hui\|Xie, Ning\|Zhao, Xin
PMID:	21459723

89.
Journal:	Hepatology. 2011 May;53(5):1549-57.
Title:	Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma.
Author:	Di Tommaso, Luca\|Destro, Annarita\|Fabbris, Valentina\|Spagnuolo, Gaia\|Laura Fracanzani, Anna\|Fargion, Silvia\|Maggioni, Marco\|Patriarca, Carlo\|Maria Macchi, Roberto\|Quagliuolo, Michela\|Borzio, Mauro\|Iavarone, Massimo\|Sangiovanni, Angelo\|Colombo, Massimo\|Ron
PMID:	21520170

90.
Journal:	Anticancer Agents Med Chem. 2011 Jul;11(6):543-8.
Title:	Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma.
Author:	Allegretta, Mark\|Filmus, Jorge
PMID:	21554204

91.
Journal:	Int J Mol Med. 2011 Oct;28(4):497-503.
Title:	Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
Author:	Ruan, Jian\|Liu, Feiye\|Chen, Xiaohua\|Zhao, Peng\|Su, Ning\|Xie, Guozhu\|Chen, Jianpeng\|Zheng, Dayong\|Luo, Rongcheng
PMID:	21617840

92.
Journal:	Cancer Sci. 2011 Sep;102(9):1622-9.
Title:	Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.
Author:	Suzuki, Shiro\|Yoshikawa, Toshiaki\|Hirosawa, Tomoya\|Shibata, Kiyosumi\|Kikkawa, Fumitaka\|Akatsuka, Yoshiki\|Nakatsura, Tetsuya
PMID:	21668581

93.
Journal:	Neoplasia. 2011 Aug;13(8):735-47.
Title:	Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-beta2.
Author:	Sun, Chris K\|Chua, Mei-Sze\|He, Jing\|So, Samuel K
PMID:	21847365

94.
Journal:	Mol Med Rep. 2011 Nov-Dec;4(6):1067-73.
Title:	A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2.
Author:	Yang, Dongye\|Yang, Junwen\|Lu, Fanggen\|Li, Caihong\|Yang, Jingbo\|Liang, Jieling
PMID:	21904776

95.
Journal:	J Clin Lab Anal. 2011;25(5):350-3.
Title:	Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma.
Author:	Ozkan, Hasan\|Erdal, Harun\|Kocak, Erdem\|Tutkak, Huseyin\|Karaeren, Zihni\|Yakut, Mustafa\|Koklu, Seyfettin
PMID:	21919070

96.
Journal:	BioDrugs. 2011 Oct 1;25(5):275-84.
Title:	Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.
Author:	Ho, Mitchell
PMID:	21942912

97.
Journal:	Hepat Mon. 2011 Mar;11(3):195-9.
Title:	Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC.
Author:	Wang, Yuliang\|Shen, Zhongyang\|Zhu, Zhijun\|Han, Ruifa\|Huai, Mingsheng
PMID:	22087143

98.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):626-9.
Title:	[Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma].
Author:	Yip, Yuk-ching\|Wang, Feng-hua\|Vong, Heong-ting\|Zhang, Meng\|Wen, Jian-ming
PMID:	22177248

99.
Journal:	Cancer Rep. 2011;1(1):14-19.
Title:	The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.
Author:	Gao, Wei\|Ho, Mitchell
PMID:	22563565

100.
Journal:	Cancer Biomark. 2011-2012;11(1):29-39.
Title:	Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
Author:	Wang, Wen\|Zhao, Lan-Juan\|Wang, Yan\|Tao, Qing-Yuan\|Feitelson, Mark A\|Zhao, Ping\|Ren, Hao\|Qi, Zhong-Tian
PMID:	22820138

101.
Journal:	J Pharm Anal. 2011 Aug;1(3):166-174.
Title:	Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3.
Author:	Zhang, Qian-Yun\|Chen, Hui\|Lin, Zhen\|Lin, Jin-Ming
PMID:	29403695

102.
Journal:	Mol Biol Rep. 2012 Jan;39(1):351-7.
Title:	Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients.
Author:	Ning, Su\|Bin, Chen\|Na, Huang\|Peng, Shen\|Yi, Ding\|Xiang-hua, Ye\|Fang-yin, Zeng\|Da-yong, Zheng\|Rong-cheng, Luo
PMID:	21655958

103.
Journal:	Ann Surg Oncol. 2012 Jul;19 Suppl 3:S455-63.
Title:	Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Author:	Yu, Ming-Chin\|Lee, Yun-Shien\|Lin, Sey-En\|Wu, Hsiang-Yao\|Chen, Tse-Ching\|Lee, Wei-Chen\|Chen, Miin-Fu\|Tsai, Chi-Neu
PMID:	21822558

104.
Journal:	Int J Oncol. 2012 Jan;40(1):63-70.
Title:	Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes.
Author:	Nobuoka, Daisuke\|Motomura, Yutaka\|Shirakawa, Hirofumi\|Yoshikawa, Toshiaki\|Kuronuma, Toshimitsu\|Takahashi, Mari\|Nakachi, Kohei\|Ishii, Hiroshi\|Furuse, Junji\|Gotohda, Naoto\|Takahashi, Shinichiro\|Nakagohri, Toshio\|Konishi, Masaru\|Kinoshita, Taira\|Komori, Hiro
PMID:	21922136

105.
Journal:	Hum Pathol. 2012 May;43(5):695-701.
Title:	Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.
Author:	Levy, Mary\|Trivedi, Anand\|Zhang, Jun\|Miles, Lili\|Mattis, Aras N\|Kim, Grace E\|Lassman, Charles\|Anders, Robert A\|Misdraji, Joseph\|Yerian, Lisa M\|Xu, Haodong\|Dhall, Deepti\|Wang, Hanlin L
PMID:	21937079

106.
Journal:	Acta Histochem. 2012 Oct;114(6):547-52.
Title:	Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
Author:	Zhang, Lijie\|Liu, Hui\|Sun, Lin\|Li, Ning\|Ding, Huiguo\|Zheng, Jie
PMID:	22119409

107.
Journal:	Gut. 2012 Oct;61(10):1481-7.
Title:	Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
Author:	Tremosini, Silvia\|Forner, Alejandro\|Boix, Loreto\|Vilana, Ramon\|Bianchi, Luis\|Reig, Maria\|Rimola, Jordi\|Rodriguez-Lope, Carlos\|Ayuso, Carmen\|Sole, Manel\|Bruix, Jordi
PMID:	22287594

108.
Journal:	Biochem Biophys Res Commun. 2012 Mar 23;419(4):656-61.
Title:	Silencing glypican-3 expression induces apoptosis in human hepatocellular carcinoma cells.
Author:	Liu, Shiyuan\|Li, Yumin\|Chen, Wei\|Zheng, Pengfei\|Liu, Tao\|He, Wenting\|Zhang, Junqiang\|Zeng, Xiangting
PMID:	22382024

109.
Journal:	FEBS Lett. 2012 Mar 23;586(6):884-91.
Title:	MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
Author:	Huang, Na\|Lin, Jing\|Ruan, Jian\|Su, Ning\|Qing, Ruzhai\|Liu, Feiye\|He, Benfu\|Lv, Chengwei\|Zheng, Dayong\|Luo, Rongcheng
PMID:	22449976

110.
Journal:	BMC Biotechnol. 2012 May 7;12:23.
Title:	Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.
Author:	Li, Yonghai\|Siegel, Donald L\|Scholler, Nathalie\|Kaplan, David E
PMID:	22564378

111.
Journal:	Clin Cancer Res. 2012 Jul 1;18(13):3686-96.
Title:	Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival.
Author:	Sawada, Yu\|Yoshikawa, Toshiaki\|Nobuoka, Daisuke\|Shirakawa, Hirofumi\|Kuronuma, Toshimitsu\|Motomura, Yutaka\|Mizuno, Shoichi\|Ishii, Hiroshi\|Nakachi, Kohei\|Konishi, Masaru\|Nakagohri, Toshio\|Takahashi, Shinichiro\|Gotohda, Naoto\|Takayama, Tadatoshi\|Yamao, Kenji
PMID:	22577059

112.
Journal:	PLoS One. 2012;7(5):e37159.
Title:	Gene expression profiling of liver cancer stem cells by RNA-sequencing.
Author:	Ho, David W Y\|Yang, Zhen Fan\|Yi, Kang\|Lam, Chi Tat\|Ng, Michael N P\|Yu, Wan Ching\|Lau, Joyce\|Wan, Timothy\|Wang, Xiaoqi\|Yan, Zhixiang\|Liu, Hang\|Zhang, Yong\|Fan, Sheung Tat
PMID:	22606345

113.
Journal:	World J Gastroenterol. 2012 May 21;18(19):2408-14.
Title:	Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.
Author:	Wang, Yu-Liang\|Zhu, Zhi-Jun\|Teng, Da-Hong\|Yao, Zhi\|Gao, Wei\|Shen, Zhong-Yang
PMID:	22654434

114.
Journal:	Hepatology. 2012 Oct;56(4):1380-90.
Title:	Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
Author:	Li, Li\|Jin, Ronghua\|Zhang, Xiaoli\|Lv, Fudong\|Liu, Lifeng\|Liu, Daojie\|Liu, Kai\|Li, Ning\|Chen, Dexi
PMID:	22706665

115.
Journal:	MAbs. 2012 Sep-Oct;4(5):592-9.
Title:	High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening.
Author:	Phung, Yen\|Gao, Wei\|Man, Yan-Gao\|Nagata, Satoshi\|Ho, Mitchell
PMID:	22820551

116.
Journal:	Int J Nanomedicine. 2012;7:4593-611.
Title:	Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.
Author:	Li, Youwei\|Chen, Zhengguang\|Li, Fei\|Wang, Jichen\|Zhang, Zongming
PMID:	22956868

117.
Journal:	Tumori. 2012 Jul-Aug;98(4):478-84.
Title:	Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
Author:	Ryu, Han Suk\|Lee, Kyounbun\|Shin, Eun\|Kim, Soo Hee\|Jing, Jin\|Jung, Hae Yeon\|Lee, Hyebin\|Jang, Ja-June
PMID:	23052165

118.
Journal:	Nutr Diabetes. 2012 Dec 3;2:e52.
Title:	Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells.
Author:	Faber, D R\|Kalkhoven, E\|Westerink, J\|Bouwman, J J\|Monajemi, H M\|Visseren, F L J
PMID:	23208413

119.
Journal:	Oncoimmunology. 2012 Nov 1;1(8):1448-1450.
Title:	A glypican-3-derived peptide vaccine against hepatocellular carcinoma.
Author:	Sawada, Yu\|Sakai, Mayuko\|Yoshikawa, Toshiaki\|Ofuji, Kazuya\|Nakatsura, Tetsuya
PMID:	23243625

120.
Journal:	Hybridoma (Larchmt). 2012 Dec;31(6):455-61.
Title:	Preparation and characterization of monoclonal antibody against glypican-3.
Author:	Ma, Rui-juan\|Wang, Sui-hai\|Qin, Shi-ni\|Wang, Xiao-bo\|Li, Gao-fei\|Li, Ming\|Xu, Wei-wen
PMID:	23244326

121.
Journal:	Nihon Rinsho. 2012 Dec;70(12):2136-41.
Title:	[The cancer specific antigen, glypican-3 (GPC3)-targeted immunotherapy].
Author:	Sawada, Yu\|Nakatsura, Tetsuya
PMID:	23259386

122.
Journal:	Cancers (Basel). 2012 Sep 1;4(3):945-68.
Title:	The expression of embryonic liver development genes in hepatitis C induced cirrhosis and hepatocellular carcinoma.
Author:	Behnke, Martha\|Reimers, Mark\|Fisher, Robert
PMID:	23667740

123.
Journal:	Hepatology. 2013 Jan;57(1):195-204.
Title:	A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Author:	Maurel, Marion\|Jalvy, Sandra\|Ladeiro, Yannick\|Combe, Chantal\|Vachet, Laetitia\|Sagliocco, Francis\|Bioulac-Sage, Paulette\|Pitard, Vincent\|Jacquemin-Sablon, Helene\|Zucman-Rossi, Jessica\|Laloo, Benoit\|Grosset, Christophe F
PMID:	22865282

124.
Journal:	J Cell Biochem. 2013 Mar;114(3):625-31.
Title:	Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP.
Author:	Miao, Hui-Lai\|Pan, Zhi-Jian\|Lei, Chang-Jiang\|Wen, Ji-Yu\|Li, Ming-Yi\|Liu, Zhong-Kao\|Qiu, Zhi-Dong\|Lin, Man-Zhou\|Chen, Nian-Ping\|Chen, Ming
PMID:	23060277

125.
Journal:	Hum Pathol. 2013 Apr;44(4):542-50.
Title:	Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
Author:	Mounajjed, Taofic\|Zhang, Lizhi\|Wu, Tsung-Teh
PMID:	23079207

126.
Journal:	FEBS J. 2013 May;280(10):2471-6.
Title:	Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
Author:	Filmus, Jorge\|Capurro, Mariana
PMID:	23305321

127.
Journal:	Int J Oncol. 2013 Mar;42(3):831-8.
Title:	Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.
Author:	Iwama, Tatsuaki\|Horie, Kazutaka\|Yoshikawa, Toshiaki\|Nobuoka, Daisuke\|Shimomura, Manami\|Sawada, Yu\|Nakatsura, Tetsuya
PMID:	23354275

128.
Journal:	Clin Cancer Res. 2013 Feb 15;19(4):920-8.
Title:	First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma.
Author:	Zhu, Andrew X\|Gold, Philip J\|El-Khoueiry, Anthony B\|Abrams, Thomas A\|Morikawa, Hideo\|Ohishi, Norihisa\|Ohtomo, Toshihiko\|Philip, Philip A
PMID:	23362325

129.
Journal:	Anal Chem. 2013 Mar 19;85(6):3166-73.
Title:	Highly specific and ultrasensitive graphene-enhanced electrochemical detection of low-abundance tumor cells using silica nanoparticles coated with antibody-conjugated quantum dots.
Author:	Wu, Yafeng\|Xue, Peng\|Kang, Yuejun\|Hui, Kam M
PMID:	23402311

130.
Journal:	Hum Vaccin Immunother. 2013 Jan;9(1):210-2.
Title:	Peptide vaccines for hepatocellular carcinoma.
Author:	Nobuoka, Daisuke\|Yoshikawa, Toshiaki\|Sawada, Yu\|Fujiwara, Toshiyoshi\|Nakatsura, Tetsuya
PMID:	23442593

131.
Journal:	Hum Vaccin Immunother. 2013 Jun;9(6):1228-33.
Title:	Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case.
Author:	Sawada, Yu\|Yoshikawa, Toshiaki\|Fujii, Satoshi\|Mitsunaga, Shuichi\|Nobuoka, Daisuke\|Mizuno, Shoichi\|Takahashi, Mari\|Yamauchi, Chisako\|Endo, Itaru\|Nakatsura, Tetsuya
PMID:	23466818

132.
Journal:	Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1083-91.
Title:	Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.
Author:	Feng, Mingqian\|Gao, Wei\|Wang, Ruoqi\|Chen, Weizao\|Man, Yan-Gao\|Figg, William Douglas\|Wang, Xin Wei\|Dimitrov, Dimiter S\|Ho, Mitchell
PMID:	23471984

133.
Journal:	Sci China Life Sci. 2013 Mar;56(3):234-9.
Title:	Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.
Author:	Yu, Juanping\|Ma, Qiang\|Zhang, Bin\|Ma, Ruijuan\|Xu, Xiguang\|Li, Mingsong\|Xu, Weiwen\|Li, Ming
PMID:	23526389

134.
Journal:	BMC Cancer. 2013 Mar 27;13:161.
Title:	A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.
Author:	Jin, Guang-Zhi\|Dong, Hui\|Yu, Wen-Long\|Li, Yan\|Lu, Xin-Yuan\|Yu, Hua\|Xian, Zhi-Hong\|Dong, Wei\|Liu, Yin-Kun\|Cong, Wen-Ming\|Wu, Meng-Chao
PMID:	23537217

135.
Journal:	Surgery. 2013 Sep;154(3):536-44.
Title:	Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
Author:	Fu, Shun-Jun\|Qi, Chao-Ying\|Xiao, Wei-Kai\|Li, Shao-Qiang\|Peng, Bao-Gang\|Liang, Li-Jian
PMID:	23601901

136.
Journal:	Clin Chim Acta. 2013 Aug 23;423:105-11.
Title:	Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
Author:	Chen, Min\|Li, Guohua\|Yan, Jian\|Lu, Xiuzhi\|Cui, Jianwei\|Ni, Zhengxian\|Cheng, Weizhong\|Qian, Gengsun\|Zhang, Jing\|Tu, Hong
PMID:	23643963

137.
Journal:	Nan Fang Yi Ke Da Xue Xue Bao. 2013 Apr;33(4):590-2, 597.
Title:	[Relationship between glypican-3 and Notch1 expressions in hepatocellular carcinoma].
Author:	Peng, Fanli\|Wu, Ziqing\|Li, Xuenong
PMID:	23644127

138.
Journal:	Zhonghua Gan Zang Bing Za Zhi. 2013 Jan;21(1):53-6.
Title:	[Preparation and in vitro study of a high molecular weight contrast agent targeting hepatoma cells].
Author:	Yang, Jing\|Zeng, Yan\|Guo, Da-Jing\|Fang, Zheng\|Zhao, Jian-Nong\|Wang, Zhi-Gang
PMID:	23663764

139.
Journal:	J Histochem Cytochem. 2013 Sep;61(9):639-48.
Title:	Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
Author:	Yao, Shuzhe\|Zhang, Jianping\|Chen, Haiyan\|Sheng, Yan\|Zhang, Xiaoying\|Liu, Zhiyan\|Zhang, Cuijuan
PMID:	23686365

140.
Journal:	Am J Surg Pathol. 2013 Jul;37(7):1058-66.
Title:	Multifocal hepatic neoplasia in 3 children with APC gene mutation.
Author:	Gupta, Anita\|Sheridan, Rachel M\|Towbin, Alexander\|Geller, James I\|Tiao, Gregory\|Bove, Kevin E
PMID:	23715166

141.
Journal:	J Cancer Res Clin Oncol. 2013 Aug;139(8):1417-24.
Title:	A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
Author:	Xu, Cheng\|Yan, Zhehui\|Zhou, Liang\|Wang, Yuming
PMID:	23743582

142.
Journal:	Br J Cancer. 2013 Aug 20;109(4):1031-9.
Title:	Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression.
Author:	Liang, J\|Ding, T\|Guo, Z-W\|Yu, X-J\|Hu, Y-Z\|Zheng, L\|Xu, J
PMID:	23868000

143.
Journal:	Int J Oncol. 2013 Oct;43(4):1019-26.
Title:	Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican3derived peptide.
Author:	Tada, Yoshitaka\|Yoshikawa, Toshiaki\|Shimomura, Manami\|Sawada, Yu\|Sakai, Mayuko\|Shirakawa, Hirofumi\|Nobuoka, Daisuke\|Nakatsura, Tetsuya
PMID:	23903757

144.
Journal:	Mol Biol Rep. 2013 Dec;40(12):7069-75.
Title:	Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Author:	Ibrahim, Gehan H\|Mahmoud, Moushira A\|Aly, Nagwa M
PMID:	24186850

145.
Journal:	J Egypt Natl Canc Inst. 2013 Dec;25(4):173-80.
Title:	Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology.
Author:	Zaakook, Mohamed\|Ayoub, Menar\|Sinna, Eman Abu\|El-Sheikh, Samar
PMID:	24207089

146.
Journal:	Am J Clin Pathol. 2013 Dec;140(6):872-80.
Title:	Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (DeltaNp63) in squamous cell and urothelial carcinoma.
Author:	Gailey, Michael P\|Bellizzi, Andrew M
PMID:	24225756

147.
Journal:	Afr Health Sci. 2013 Sep;13(3):703-9.
Title:	Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.
Author:	Li, B\|Liu, H\|Shang, H W\|Li, P\|Li, N\|Ding, H G
PMID:	24250310

148.
Journal:	J Gastrointestin Liver Dis. 2013 Dec;22(4):419-25.
Title:	New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.
Author:	Saad, Yasmin\|El-Serafy, Magdy\|Eldin, Mona S\|Abdellatif, Zeinab\|Khatab, Hany\|Elbaz, Tamer\|Elgarem, Hasan
PMID:	24369324

149.
Journal:	Asian Pac J Cancer Prev. 2013;14(12):7345-9.
Title:	Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
Author:	Abdelgawad, Iman Attia\|Mossallam, Ghada Ibrahim\|Radwan, Noha Hassan\|Elzawahry, Heba Mohammed\|Elhifnawy, Niveen Mostafa
PMID:	24460300

150.
Journal:	J Gastroenterol. 2014 Jan;49(1):117-25.
Title:	Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy.
Author:	Chen, I-Pei\|Ariizumi, Shun-ichi\|Nakano, Masayuki\|Yamamoto, Masakazu
PMID:	23532638

151.
Journal:	Hepatol Res. 2014 Mar;44(3):338-48.
Title:	MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.
Author:	Miao, Hui-Lai\|Lei, Chang-Jiang\|Qiu, Zhi-Dong\|Liu, Zhong-Kao\|Li, Ran\|Bao, Shi-Ting\|Li, Ming-Yi
PMID:	23607462

152.
Journal:	FEBS Lett. 2014 Jan 21;588(2):377-82.
Title:	Glypican-3 antibodies: a new therapeutic target for liver cancer.
Author:	Feng, Mingqian\|Ho, Mitchell
PMID:	24140348

153.
Journal:	Hum Vaccin Immunother. 2014;10(2):338-43.
Title:	Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports.
Author:	Suzuki, Shiro\|Shibata, Kiyosumi\|Kikkawa, Fumitaka\|Nakatsura, Tetsuya
PMID:	24252799

154.
Journal:	Liver Int. 2014 Jul;34(6):942-52.
Title:	Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
Author:	Ohno, Akinobu\|Yorita, Kenji\|Haruyama, Yukihiro\|Kondo, Kazuhiro\|Kato, Atsuhiko\|Ohtomo, Toshihiko\|Kawaguchi, Makiko\|Marutuska, Kousuke\|Chijiiwa, Kazuo\|Kataoka, Hiroaki
PMID:	24433439

155.
Journal:	J Surg Res. 2014 Apr;187(2):377-85.
Title:	The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling.
Author:	Magistri, Paolo\|Leonard, Stephanie Y\|Tang, Chih-Min\|Chan, Jonathan C\|Lee, Tracy E\|Sicklick, Jason K
PMID:	24439425

156.
Journal:	PLoS One. 2014 Jan 13;9(1):e84807.
Title:	Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners.
Author:	Chiba, Tetsuhiro\|Suzuki, Eiichiro\|Yuki, Kaori\|Zen, Yoh\|Oshima, Motohiko\|Miyagi, Satoru\|Saraya, Atsunori\|Koide, Shuhei\|Motoyama, Tenyu\|Ogasawara, Sadahisa\|Ooka, Yoshihiko\|Tawada, Akinobu\|Nakatsura, Tetsuya\|Hayashi, Takehiro\|Yamashita, Taro\|Kaneko, Syuichi\|
PMID:	24454751

157.
Journal:	Hepatology. 2014 Aug;60(2):576-87.
Title:	Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.
Author:	Gao, Wei\|Kim, Heungnam\|Feng, Mingqian\|Phung, Yen\|Xavier, Charles P\|Rubin, Jeffrey S\|Ho, Mitchell
PMID:	24492943

158.
Journal:	J Cell Sci. 2014 Apr 1;127(Pt 7):1565-75.
Title:	Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling.
Author:	Capurro, Mariana\|Martin, Tonya\|Shi, Wen\|Filmus, Jorge
PMID:	24496449

159.
Journal:	PLoS One. 2014 Jan 31;9(1):e87120.
Title:	Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.
Author:	Gong, Li\|Wei, Long-Xiao\|Ren, Pin\|Zhang, Wen-Dong\|Liu, Xiao-Yan\|Han, Xiu-Juan\|Yao, Li\|Zhu, Shao-Jun\|Lan, Miao\|Li, Yan-Hong\|Zhang, Wei
PMID:	24498024

160.
Journal:	Cancer Sci. 2014 Apr;105(4):455-62.
Title:	Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma.
Author:	Ikeda, Masafumi\|Ohkawa, Shinichi\|Okusaka, Takuji\|Mitsunaga, Shuichi\|Kobayashi, Satoshi\|Morizane, Chigusa\|Suzuki, Ikue\|Yamamoto, Shunsuke\|Furuse, Junji
PMID:	24521523

161.
Journal:	BMC Cancer. 2014 Feb 18;14:104.
Title:	Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
Author:	Xiao, Wei-Kai\|Qi, Chao-Ying\|Chen, Dong\|Li, Shao-Qiang\|Fu, Shun-Jun\|Peng, Bao-Gang\|Liang, Li-Jian
PMID:	24548704

162.
Journal:	J Nucl Med. 2014 May;55(5):799-804.
Title:	Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.
Author:	Sham, Jonathan G\|Kievit, Forrest M\|Grierson, John R\|Miyaoka, Robert S\|Yeh, Matthew M\|Zhang, Miqin\|Yeung, Raymond S\|Minoshima, Satoshi\|Park, James O
PMID:	24627434

163.
Journal:	Gut Liver. 2014 Mar;8(2):177-85.
Title:	Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.
Author:	Lee, Hyun Jung\|Yeon, Jong Eun\|Suh, Sang Jun\|Lee, Sun Jae\|Yoon, Eileen L\|Kang, Keunhee\|Yoo, Yang Jae\|Kim, Ji Hoon\|Seo, Yeon Seok\|Yim, Hyung Joon\|Byun, Kwan Soo
PMID:	24672660

164.
Journal:	PLoS One. 2014 Apr 1;9(4):e93599.
Title:	Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice.
Author:	Yi, Xu\|Long, Li\|Yang, Chunzhang\|Lu, Yingying\|Cheng, Mingliang
PMID:	24690765

165.
Journal:	Zhonghua Gan Zang Bing Za Zhi. 2014 Feb;22(2):142-7.
Title:	[Preparation of a glypican-3-targeting hepatocellular carcinoma MR probe and its molecular imaging in HepG2 cells].
Author:	Gu, Yan\|Zeng, Yan\|Guo, Da-Jing\|Yang, Jing\|Zhou, Jun\|Liu, Xin-Jie\|Wang, Zhi-Gang
PMID:	24735598

166.
Journal:	Biomaterials. 2014 Aug;35(25):6964-71.
Title:	Imaging of hepatocellular carcinoma patient-derived xenografts using (8)(9)Zr-labeled anti-glypican-3 monoclonal antibody.
Author:	Yang, Xiaoyang\|Liu, Hongguang\|Sun, Chris K\|Natarajan, Arutselvan\|Hu, Xiang\|Wang, Xiaolin\|Allegretta, Mark\|Guttmann, Ronald D\|Gambhir, Sanjiv S\|Chua, Mei-Sze\|Cheng, Zhen\|So, Samuel K
PMID:	24836949

167.
Journal:	World J Gastroenterol. 2014 May 28;20(20):6336-44.
Title:	Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Author:	Li, Jia\|Gao, Jian-Zhi\|Du, Jing-Li\|Wei, Li-Xin
PMID:	24876756

168.
Journal:	Hepatogastroenterology. 2014 Mar-Apr;61(130):278-84.
Title:	GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.
Author:	Li, Shao-Qiang\|Lin, Jie\|Qi, Chao-Ying\|Fu, Shun-Jun\|Xiao, Wei-Kai\|Peng, Bao-Gang\|Liang, Li-Jian
PMID:	24901124

169.
Journal:	Analyst. 2014 Aug 7;139(15):3744-7.
Title:	A sensitive method for protein assays using a peptide-based nano-label: human glypican-3 detection for hepatocellular carcinomas diagnosis.
Author:	Huang, Yue\|Li, Hao\|Gao, Tao\|Liu, Xinjian\|Li, Genxi
PMID:	24909227

170.
Journal:	World J Gastroenterol. 2014 May 21;20(19):5826-38.
Title:	Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.
Author:	Mu, Hong\|Lin, Kai-Xuan\|Zhao, Hong\|Xing, Shu\|Li, Cong\|Liu, Fang\|Lu, Hai-Zhen\|Zhang, Ze\|Sun, Yu-Lin\|Yan, Xi-Yun\|Cai, Jian-Qiang\|Zhao, Xiao-Hang
PMID:	24914343

171.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2014 Apr;43(4):246-50.
Title:	[Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Author:	Li, Jie\|Wei, Lixin
PMID:	24915815

172.
Journal:	Cancer Chemother Pharmacol. 2014 Aug;74(2):323-32.
Title:	Circulating biomarkers in hepatocellular carcinoma.
Author:	Morris, Karen L\|Tugwood, Jonathan D\|Khoja, Leila\|Lancashire, Matthew\|Sloane, Robert\|Burt, Debbie\|Shenjere, Patrick\|Zhou, Cong\|Hodgson, Clare\|Ohtomo, Toshihiko\|Katoh, Atsuhiko\|Ishiguro, Takahiro\|Valle, Juan W\|Dive, Caroline
PMID:	24923562

173.
Journal:	Asian Pac J Trop Med. 2014 Oct;7(10):780-6.
Title:	Lentivirus vectors construction of SiRNA targeting interference GPC3 gene and its biological effects on liver cancer cell lines Huh-7.
Author:	Lei, Chang-Jiang\|Yao, Chun\|Pan, Qing-Yun\|Long, Hao-Cheng\|Li, Lei\|Zheng, Shu-Ping\|Zeng, Cheng\|Huang, Jian-Bin
PMID:	25129460

174.
Journal:	Int J Biochem Cell Biol. 2014 Oct;55:129-35.
Title:	Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
Author:	Luan, Fang\|Liu, Peng\|Ma, Hongxin\|Yue, Xuetian\|Liu, Jun\|Gao, Lifen\|Liang, Xiaohong\|Ma, Chunhong
PMID:	25195714

175.
Journal:	Mol Med Rep. 2014 Dec;10(6):3177-84.
Title:	Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells.
Author:	Qi, Xin-Hui\|Wu, Di\|Cui, Hui-Xia\|Ma, Nan\|Su, Jia\|Wang, Yu-Tong\|Jiang, You-Hong
PMID:	25270552

176.
Journal:	Clin Cancer Res. 2014 Dec 15;20(24):6418-28.
Title:	Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma.
Author:	Gao, Huiping\|Li, Kesang\|Tu, Hong\|Pan, Xiaorong\|Jiang, Hua\|Shi, Bizhi\|Kong, Juan\|Wang, Hongyang\|Yang, Shengli\|Gu, Jianren\|Li, Zonghai
PMID:	25320357

177.
Journal:	J Nucl Med. 2014 Dec;55(12):2032-7.
Title:	Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
Author:	Sham, Jonathan G\|Kievit, Forrest M\|Grierson, John R\|Chiarelli, Peter A\|Miyaoka, Robert S\|Zhang, Miqin\|Yeung, Raymond S\|Minoshima, Satoshi\|Park, James O
PMID:	25359880

178.
Journal:	Dis Markers. 2014;2014:127831.
Title:	Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literature.
Author:	Yang, Sheng-Li\|Fang, Xiefan\|Huang, Zao-Zao\|Liu, Xiang-Jie\|Xiong, Zhi-Fan\|Liu, Ping\|Yao, Hong-Yi\|Li, Chang-Hai
PMID:	25378766

179.
Journal:	Arch Med Res. 2014 Oct;45(7):580-8.
Title:	Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
Author:	Jia, Xiaobo\|Liu, Jiao\|Gao, Yingtang\|Huang, Yong\|Du, Zhi
PMID:	25446613

180.
Journal:	J Hepatocell Carcinoma. 2014 May 21;1:35-42.
Title:	Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.
Author:	Ofuji, Kazuya\|Saito, Keigo\|Yoshikawa, Toshiaki\|Nakatsura, Tetsuya
PMID:	27508174

181.
Journal:	J Clin Lab Anal. 2015 Mar;29(2):85-93.
Title:	Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.
Author:	Yu, Juan-Ping\|Xu, Xi-Guang\|Ma, Rui-Juan\|Qin, Shi-Ni\|Wang, Cong-Rong\|Wang, Xiao-Bo\|Li, Ming\|Li, Ming-Song\|Ma, Qiang\|Xu, Wei-Wen
PMID:	24687454

182.
Journal:	Pathol Oncol Res. 2015 Apr;21(2):379-87.
Title:	Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
Author:	Ibrahim, Taiseer R\|Abdel-Raouf, Samar M
PMID:	25108409

183.
Journal:	Eur J Pediatr Surg. 2015 Feb;25(1):138-44.
Title:	Glypican 3 expression in pediatric malignant solid tumors.
Author:	Kinoshita, Yoshiaki\|Tanaka, Sakura\|Souzaki, Ryota\|Miyoshi, Kina\|Kohashi, Kenichi\|Oda, Yoshinao\|Nakatsura, Tetsuya\|Taguchi, Tomoaki
PMID:	25344940

184.
Journal:	Int J Oncol. 2015 Jan;46(1):28-36.
Title:	Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes.
Author:	Sawada, Yu\|Yoshikawa, Toshiaki\|Shimomura, Manami\|Iwama, Tatsuaki\|Endo, Itaru\|Nakatsura, Tetsuya
PMID:	25354479

185.
Journal:	Virchows Arch. 2015 Jan;466(1):67-76.
Title:	Glypican 3 overexpression in primary and metastatic Wilms tumors.
Author:	Tretiakova, Maria\|Zynger, Debra L\|Luan, Chunyan\|Andeen, Nicole K\|Finn, Laura S\|Kocherginsky, Masha\|Teh, Bin T\|Yang, Ximing J
PMID:	25366870

186.
Journal:	Med Oncol. 2015 Jan;32(1):359.
Title:	Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software.
Author:	Pan, Chenwei\|Wang, Xiaodong\|Chen, Weilai\|Tao, Chonglin\|Xu, Xiaowu\|Jin, Lingxiang\|Chen, Yongping\|Zhu, Lihe\|Zhou, Lingli\|Pan, Zhenzhen
PMID:	25432695

187.
Journal:	Eur J Pharmacol. 2015 Jan 5;746:353-62.
Title:	Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Author:	Zaghloul, Randa A\|El-Shishtawy, Mamdouh M\|El Galil, Khaled H Abd\|Ebrahim, Mohamed A\|Metwaly, AbdelHamid A\|Al-Gayyar, Mohammed M
PMID:	25449037

188.
Journal:	Int J Biol Markers. 2015 Feb 24;30(1):e32-42.
Title:	Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
Author:	Hussein, Tarek D
PMID:	25450646

189.
Journal:	Biosens Bioelectron. 2015 Apr 15;66:399-404.
Title:	Enzyme-free and label-free fluorescence sensor for the detection of liver cancer related short gene.
Author:	Li, Xianghui\|Gan, Longjie\|Ou, Qishui\|Zhang, Xi\|Cai, Shuxian\|Wu, Dongzhi\|Chen, Mei\|Xia, Yaokun\|Chen, Jinghua\|Yang, Bin
PMID:	25483916

190.
Journal:	Carcinogenesis. 2015 Feb;36(2):232-42.
Title:	Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Author:	Liu, Xiyong\|Wang, Sean K\|Zhang, Keqiang\|Zhang, Hang\|Pan, Qin\|Liu, Zhiwei\|Pan, Hongming\|Xue, Lijun\|Yen, Yun\|Chu, Peiguo G
PMID:	25542894

191.
Journal:	Int J Oncol. 2015 Mar;46(3):1275-85.
Title:	Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
Author:	Wu, Yongle\|Liu, Hui\|Weng, Honglei\|Zhang, Xin\|Li, Peng\|Fan, Chun-Lei\|Li, Bing\|Dong, Pei-Ling\|Li, Lei\|Dooley, Steven\|Ding, Hui-Guo
PMID:	25572615

192.
Journal:	Mol Med Rep. 2015 May;11(5):3361-7.
Title:	Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.
Author:	Wang, Yuliang\|Wang, Yinlong\|Mu, Hong\|Liu, Tao\|Chen, Xiaobo\|Shen, Zhongyang
PMID:	25625609

193.
Journal:	J Biol Chem. 2015 Mar 20;290(12):7576-85.
Title:	Processing by convertases is required for glypican-3-induced inhibition of Hedgehog signaling.
Author:	Capurro, Mariana\|Shi, Wen\|Izumikawa, Tomomi\|Kitagawa, Hiroshi\|Filmus, Jorge
PMID:	25653284

194.
Journal:	Int J Clin Exp Pathol. 2015 Jan 1;8(1):995-9. eCollection 2015.
Title:	Simultaneous double primary clear cell carcinomas of liver and kidney: a case report and review of literature.
Author:	Zhang, Wei\|Wang, Qiang\|Jiang, Yan-Xia\|Lu, Qing\|Yu, Wen-Juan\|Liu, Yan\|Liu, Yu-Lin\|Zhao, Hui\|Zhuang, Jie\|Li, Yu-Jun
PMID:	25755808

195.
Journal:	Int J Cancer. 2015 Oct 1;137(7):1643-51.
Title:	High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy.
Author:	Haruyama, Yukihiro\|Yorita, Kenji\|Yamaguchi, Tetsuji\|Kitajima, Sachiko\|Amano, Jun\|Ohtomo, Toshihiko\|Ohno, Akinobu\|Kondo, Kazuhiro\|Kataoka, Hiroaki
PMID:	25784484

196.
Journal:	Anticancer Res. 2015 Apr;35(4):2021-8.
Title:	Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.
Author:	Hass, Holger G\|Jobst, Juergen\|Scheurlen, Michael\|Vogel, Ulrich\|Nehls, Oliver
PMID:	25862856

197.
Journal:	World J Gastroenterol. 2015 Apr 14;21(14):4275-83.
Title:	Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
Author:	Li, You-Wei\|Chen, Zheng-Guang\|Zhao, Zhou-She\|Li, Hong-Li\|Wang, Ji-Chen\|Zhang, Zong-Ming
PMID:	25892879

198.
Journal:	Diagn Pathol. 2015 Apr 21;10:34.
Title:	Expression of Glypican 3 in low and high grade urothelial carcinomas.
Author:	Aydin, Oguz\|Yildiz, Levent\|Baris, Sancar\|Dundar, Cihad\|Karagoz, Filiz
PMID:	25896897

199.
Journal:	Nanomedicine (Lond). 2015;10(7):1139-47.
Title:	Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel.
Author:	Hanaoka, Hirofumi\|Nakajima, Takahito\|Sato, Kazuhide\|Watanabe, Rira\|Phung, Yen\|Gao, Wei\|Harada, Toshiko\|Kim, Insook\|Paik, Chang H\|Choyke, Peter L\|Ho, Mitchell\|Kobayashi, Hisataka
PMID:	25929570

200.
Journal:	Histopathology. 2015 Dec;67(6):905-13.
Title:	Quantification of glypican 3, beta-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Author:	Zhou, Shengmei\|Parham, David M\|Yung, Evan\|Pattengale, Paul\|Wang, Larry
PMID:	25939253

201.
Journal:	ACS Appl Mater Interfaces. 2015 May 27;7(20):10935-43.
Title:	Multifunctional biocompatible graphene oxide quantum dots decorated magnetic nanoplatform for efficient capture and two-photon imaging of rare tumor cells.
Author:	Shi, Yongliang\|Pramanik, Avijit\|Tchounwou, Christine\|Pedraza, Francisco\|Crouch, Rebecca A\|Chavva, Suhash Reddy\|Vangara, Aruna\|Sinha, Sudarson Sekhar\|Jones, Stacy\|Sardar, Dhiraj\|Hawker, Craig\|Ray, Paresh Chandra
PMID:	25939643

202.
Journal:	Mol Pharm. 2015 Jun 1;12(6):2151-7.
Title:	Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapy.
Author:	Hanaoka, Hirofumi\|Nagaya, Tadanobu\|Sato, Kazuhide\|Nakamura, Yuko\|Watanabe, Rira\|Harada, Toshiko\|Gao, Wei\|Feng, Mingqian\|Phung, Yen\|Kim, Insook\|Paik, Chang H\|Choyke, Peter L\|Ho, Mitchell\|Kobayashi, Hisataka
PMID:	25955255

203.
Journal:	Tumour Biol. 2015 Sep;36(10):7997-8006.
Title:	Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Author:	Liu, Ying\|Zheng, Dongping\|Liu, Mingming\|Bai, Jiao\|Zhou, Xi\|Gong, Baolan\|Lu, Jieyu\|Zhang, Yi\|Huang, Hui\|Luo, Wenying\|Huang, Guangrong
PMID:	25967456

204.
Journal:	Asian Pac J Cancer Prev. 2015;16(9):3595-604.
Title:	Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Author:	Wang, Chun-Hsiang\|Wey, Keh-Cherng\|Mo, Lein-Ray\|Chang, Kuo-Kwan\|Lin, Ruey-Chang\|Kuo, Jen-Juan
PMID:	25987009

205.
Journal:	Cancer Sci. 2015 Aug;106(8):972-81.
Title:	Differential reactivation of fetal/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions.
Author:	Chen, Xi\|Yamamoto, Masahiro\|Fujii, Kiyonaga\|Nagahama, Yasuharu\|Ooshio, Takako\|Xin, Bing\|Okada, Yoko\|Furukawa, Hiroyuki\|Nishikawa, Yuji
PMID:	26011625

206.
Journal:	Gastroenterology. 2015 Oct;149(4):1042-52.
Title:	T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
Author:	Dargel, Christina\|Bassani-Sternberg, Michal\|Hasreiter, Julia\|Zani, Fabio\|Bockmann, Jan-Hendrik\|Thiele, Frank\|Bohne, Felix\|Wisskirchen, Karin\|Wilde, Susanne\|Sprinzl, Martin F\|Schendel, Dolores J\|Krackhardt, Angela M\|Uckert, Wolfgang\|Wohlleber, Dirk\|Schiema
PMID:	26052074

207.
Journal:	Asian Pac J Cancer Prev. 2015;16(11):4769-75.
Title:	Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions.
Author:	Wasfy, Rania Elsayed\|Shams Eldeen, Aliaa Atef
PMID:	26107238

208.
Journal:	PLoS One. 2015 Sep 2;10(9):e0137664.
Title:	Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.
Author:	Gao, Wei\|Kim, Heungnam\|Ho, Mitchell
PMID:	26332121

209.
Journal:	Cancer Biomark. 2015;15(5):677-83.
Title:	Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Author:	Zhao, Yunsheng\|Wang, Meng\|Cui, Chenying\|Zhang, Lina\|Liao, Fei\|Li, Hongchen\|Wu, Xia
PMID:	26406957

210.
Journal:	Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3655-73.
Title:	Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
Author:	Liu, J-W\|Zuo, X-L\|Wang, S
PMID:	26502856

211.
Journal:	J Hepatol. 2016 Jan;64(1):87-93.
Title:	Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications.
Author:	Sciarra, Amedeo\|Di Tommaso, Luca\|Nakano, Masayuki\|Destro, Annarita\|Torzilli, Guido\|Donadon, Matteo\|Maggioni, Marco\|Bosari, Silvano\|Bulfamante, Gaetano\|Matsuda, Masanori\|Fujii, Hideki\|Ichikawa, Tomoaki\|Morisaka, Hiroyuki\|Sano, Katsuhiro\|Ichikawa, Shintaro\|
PMID:	26343958

212.
Journal:	Biosci Trends. 2016 May 23;10(2):85-91.
Title:	Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials.
Author:	Sun, Zhipeng\|Zhu, Yubing\|Xia, Jufeng\|Sawakami, Tatsuo\|Kokudo, Norihiro\|Zhang, Nengwei
PMID:	26522694

213.
Journal:	Analyst. 2016 Jan 7;141(1):36-44.
Title:	Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.
Author:	Waidely, Eric\|Al-Yuobi, Abdul-Rahman Obaid\|Bashammakh, A S\|El-Shahawi, Mohammad S\|Leblanc, Roger M
PMID:	26606739

214.
Journal:	Biochem Biophys Res Commun. 2016 Jan 1;469(1):138-143.
Title:	Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.
Author:	Iwama, Tatsuaki\|Uchida, Tetsuya\|Sawada, Yu\|Tsuchiya, Nobuhiro\|Sugai, Shiori\|Fujinami, Norihiro\|Shimomura, Manami\|Yoshikawa, Toshiaki\|Zhang, Rong\|Uemura, Yasushi\|Nakatsura, Tetsuya
PMID:	26616051

215.
Journal:	Small. 2016 Jan 27;12(4):477-87.
Title:	Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
Author:	Wang, Kui\|Kievit, Forrest M\|Sham, Jonathan G\|Jeon, Mike\|Stephen, Zachary R\|Bakthavatsalam, Arvind\|Park, James O\|Zhang, Miqin
PMID:	26641029

216.
Journal:	World J Gastroenterol. 2016 Jan 7;22(1):275-83.
Title:	Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.
Author:	Haruyama, Yukihiro\|Kataoka, Hiroaki
PMID:	26755876

217.
Journal:	APMIS. 2016 Mar;124(3):208-15.
Title:	Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.
Author:	Jeon, Yejoo\|Kim, Haeryoung\|Jang, Eun Sun\|Hong, Sukho\|Kim, Jin Wook\|Yoon, Yoo-Seok\|Cho, Jai Young\|Han, Ho-Seong\|Jeong, Sook-Hyang
PMID:	26764243

218.
Journal:	Bioconjug Chem. 2016 Mar 16;27(3):831-9.
Title:	Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging.
Author:	Zhu, Dongling\|Qin, Yushuang\|Wang, Jingjing\|Zhang, Liwen\|Zou, Sijuan\|Zhu, Xiaohua\|Zhu, Lei
PMID:	26850086

219.
Journal:	Oncoimmunology. 2015 Aug 31;5(1):e1062209.
Title:	Identification of glypican-3-derived long peptides activating both CD8(+) and CD4(+) T cells; prolonged overall survival in cancer patients with Th cell response.
Author:	Sayem, Mohammad A\|Tomita, Yusuke\|Yuno, Akira\|Hirayama, Masatoshi\|Irie, Atsushi\|Tsukamoto, Hirotake\|Senju, Satoru\|Yuba, Eiji\|Yoshikawa, Toshiaki\|Kono, Kenji\|Nakatsura, Tetsuya\|Nishimura, Yasuharu
PMID:	26942076

220.
Journal:	PLoS One. 2016 Mar 15;11(3):e0151501.
Title:	CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
Author:	Feng, Jiliang\|Zhu, Ruidong\|Chang, Chun\|Yu, Lu\|Cao, Fang\|Zhu, Guohua\|Chen, Feng\|Xia, Hui\|Lv, Fudong\|Zhang, Shijie\|Sun, Lin
PMID:	26977595

221.
Journal:	PLoS One. 2016 Apr 13;11(4):e0153613.
Title:	Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.
Author:	Montalbano, Mauro\|Curcuru, Giuseppe\|Shirafkan, Ali\|Vento, Renza\|Rastellini, Cristiana\|Cicalese, Luca
PMID:	27074018

222.
Journal:	J Hepatol. 2016 Aug;65(2):289-95.
Title:	Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma.
Author:	Abou-Alfa, Ghassan K\|Puig, Oscar\|Daniele, Bruno\|Kudo, Masatoshi\|Merle, Philippe\|Park, Joong-Won\|Ross, Paul\|Peron, Jean-Marie\|Ebert, Oliver\|Chan, Stephen\|Poon, Tung Ping\|Colombo, Massimo\|Okusaka, Takuji\|Ryoo, Baek-Yeol\|Minguez, Beatriz\|Tanaka, Takayoshi\|Oh
PMID:	27085251

223.
Journal:	Exp Cell Res. 2016 May 1;343(2):135-147.
Title:	MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Author:	Tian, Zhijie\|Jiang, Hequn\|Liu, Ying\|Huang, Yong\|Xiong, Xin\|Wu, Hongwei\|Dai, Xiaozhen
PMID:	27090017

224.
Journal:	Int J Immunogenet. 2016 Jun;43(3):166-70.
Title:	*Prediction and preliminary screening of HLA-A0201-restricted epitope peptides of human GPC3.**
Author:	Hu, P\|Wei, Z\|Li, R\|Wu, D\|Meng, Z
PMID:	27102087

225.
Journal:	Tumour Biol. 2016 Sep;37(9):12113-12121.
Title:	Targeted nanobubbles in low-frequency ultrasound-mediated gene transfection and growth inhibition of hepatocellular carcinoma cells.
Author:	Wu, Bolin\|Qiao, Qiang\|Han, Xue\|Jing, Hui\|Zhang, Hao\|Liang, Hongjian\|Cheng, Wen
PMID:	27216880

226.
Journal:	Biosens Bioelectron. 2016 Nov 15;85:633-640.
Title:	Biofunctionalized magnetic nanospheres-based cell sorting strategy for efficient isolation, detection and subtype analyses of heterogeneous circulating hepatocellular carcinoma cells.
Author:	Chen, Lan\|Wu, Ling-Ling\|Zhang, Zhi-Ling\|Hu, Jiao\|Tang, Man\|Qi, Chu-Bo\|Li, Na\|Pang, Dai-Wen
PMID:	27240010

227.
Journal:	Endocr Pathol. 2016 Sep;27(3):253-8.
Title:	Liver Metastases of Neuroendocrine Tumors Rarely Show Overlapping Immunoprofile with Hepatocellular Carcinomas.
Author:	Jin, Ming\|Zhou, Xiaoping\|Yearsley, Martha\|Frankel, Wendy L
PMID:	27300354

228.
Journal:	Tumour Biol. 2016 Sep;37(9):12571-12577.
Title:	GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.
Author:	Attallah, Abdelfattah M\|El-Far, Mohamed\|Omran, Mohamed M\|Abdelrazek, Mohamed A\|Attallah, Ahmed A\|Saeed, Aya M\|Farid, Khaled
PMID:	27380057

229.
Journal:	Oncoimmunology. 2016 Jan 19;5(5):e1129483.
Title:	Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients.
Author:	Sawada, Yu\|Yoshikawa, Toshiaki\|Ofuji, Kazuya\|Yoshimura, Mayuko\|Tsuchiya, Nobuhiro\|Takahashi, Mari\|Nobuoka, Daisuke\|Gotohda, Naoto\|Takahashi, Shinichiro\|Kato, Yuichiro\|Konishi, Masaru\|Kinoshita, Taira\|Ikeda, Masafumi\|Nakachi, Kohei\|Yamazaki, Naoya\|Mizuno,
PMID:	27467945

230.
Journal:	Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):371-7.
Title:	Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
Author:	Gao, Feng\|Zhu, Heng-Kai\|Zhu, Yang-Bo\|Shan, Qiao-Nan\|Ling, Qi\|Wei, Xu-Yong\|Xie, Hai-Yang\|Zhou, Lin\|Xu, Xiao\|Zheng, Shu-Sen
PMID:	27498576

231.
Journal:	Chin J Cancer. 2016 Aug 24;35(1):82.
Title:	Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Author:	Zhao, Qian\|Yu, Wen-Long\|Lu, Xin-Yuan\|Dong, Hui\|Gu, Yi-Jin\|Sheng, Xia\|Cong, Wen-Ming\|Wu, Meng-Chao
PMID:	27552844

232.
Journal:	J Gastrointest Oncol. 2016 Aug;7(4):570-9.
Title:	A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.
Author:	Mok, Shaffer R S\|Mohan, Sachin\|Grewal, Navjot\|Elfant, Adam B\|Judge, Thomas A
PMID:	27563447

233.
Journal:	FEBS J. 2016 Oct;283(20):3739-3754.
Title:	Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Author:	Zhu, Xiao-Ting\|Yuan, Ji-Hang\|Zhu, Teng-Teng\|Li, Yang-Yang\|Cheng, Xiao-Yang
PMID:	27573079

234.
Journal:	Angew Chem Int Ed Engl. 2016 Sep 26;55(40):12372-5.
Title:	Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution.
Author:	Zhang, Liqin\|Yang, Zunyi\|Le Trinh, Thu\|Teng, I-Ting\|Wang, Sai\|Bradley, Kevin M\|Hoshika, Shuichi\|Wu, Qunfeng\|Cansiz, Sena\|Rowold, Diane J\|McLendon, Christopher\|Kim, Myong-Sang\|Wu, Yuan\|Cui, Cheng\|Liu, Yuan\|Hou, Weijia\|Stewart, Kimberly\|Wan, Shuo\|Liu, Chen\|
PMID:	27601357

235.
Journal:	Asian Pac J Trop Med. 2016 Sep;9(9):898-902.
Title:	Effect of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7.
Author:	Lei, Chang-Jiang\|Yao, Chun\|Li, De-Ke\|Long, Zhi-Xiong\|Li, Yuan\|Tao, Dan\|Liou, Yan-Ping\|Zhang, Jiang-Zhou\|Liu, Ning
PMID:	27633306

236.
Journal:	Oncotarget. 2016 Nov 8;7(45):73754-73768.
Title:	Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Author:	Jung, Jae Woo\|Yoon, So-Mi\|Kim, Subin\|Jeon, Yun-Hui\|Yoon, Byung-Hak\|Yang, Su-Geun\|Kim, Min Kyoung\|Choe, Senyon\|Kuo, Mario Meng-Chiang
PMID:	27650540

237.
Journal:	Oncotarget. 2016 Oct 25;7(43):69916-69926.
Title:	Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.
Author:	Kaseb, Ahmed Omar\|Hassan, Manal\|Lacin, Sahin\|Abdel-Wahab, Reham\|Amin, Hesham M\|Shalaby, Ahmed\|Wolff, Robert A\|Yao, James\|Rashid, Asif\|Vennapusa, Bharathi\|Feng, Janine\|Ohtomo, Toshihiko
PMID:	27655712

238.
Journal:	Sci Rep. 2016 Sep 26;6:33878.
Title:	Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma.
Author:	Zhang, Yi-Fan\|Ho, Mitchell
PMID:	27667400

239.
Journal:	Toxins (Basel). 2016 Sep 22;8(10). pii: toxins8100274.
Title:	Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer.
Author:	Fleming, Bryan D\|Ho, Mitchell
PMID:	27669301

240.
Journal:	Anal Chim Acta. 2016 Oct 19;941:87-93.
Title:	Peroxidase-like catalytic activity of copper ions and its application for highly sensitive detection of glypican-3.
Author:	Zheng, Aixian\|Zhang, Xiaolong\|Gao, Ju\|Liu, Xiaolong\|Liu, Jingfeng
PMID:	27692382

241.
Journal:	Clin Mol Hepatol. 2016 Sep;22(3):359-365.
Title:	Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
Author:	Jeon, Yejoo\|Jang, Eun Sun\|Choi, Yun Suk\|Kim, Jin-Wook\|Jeong, Sook-Hyang
PMID:	27729630

242.
Journal:	J Hepatocell Carcinoma. 2016 Nov 8;3:63-67.
Title:	GPC-3 in hepatocellular carcinoma: current perspectives.
Author:	Wu, Yongle\|Liu, Hui\|Ding, Huiguo
PMID:	27878117

243.
Journal:	Front Immunol. 2017 Jan 11;7:690.
Title:	Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma.
Author:	Jiang, Zhiwu\|Jiang, Xiaofeng\|Chen, Suimin\|Lai, Yunxin\|Wei, Xinru\|Li, Baiheng\|Lin, Simiao\|Wang, Suna\|Wu, Qiting\|Liang, Qiubin\|Liu, Qifa\|Peng, Muyun\|Yu, Fenglei\|Weng, Jianyu\|Du, Xin\|Pei, Duanqing\|Liu, Pentao\|Yao, Yao\|Xue, Ping\|Li, Peng
PMID:	28123387

244.
Journal:	Pathol Oncol Res. 2017 Jan;23(1):33-39.
Title:	Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
Author:	Reis, Henning\|Bertram, Stefanie\|Pott, Leona\|Canbay, Ali\|Gallinat, Anja\|Baba, Hideo Andreas
PMID:	27276915

245.
Journal:	Oncotarget. 2017 May 16;8(20):32450-32460.
Title:	Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy.
Author:	Wang, Chunguang\|Gao, Wei\|Feng, Mingqian\|Pastan, Ira\|Ho, Mitchell
PMID:	27419635

246.
Journal:	Hum Gene Ther. 2017 May;28(5):437-448.
Title:	Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.
Author:	Li, Wenpeng\|Guo, Linjie\|Rathi, Purva\|Marinova, Ekaterina\|Gao, Xiuhua\|Wu, Meng-Feng\|Liu, Hao\|Dotti, Gianpietro\|Gottschalk, Stephen\|Metelitsa, Leonid S\|Heczey, Andras
PMID:	27530312

247.
Journal:	Macromol Biosci. 2017 Apr;17(4).
Title:	Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.
Author:	Qin, Zainen\|Wang, Jingjing\|Wang, Ye\|Wang, Guohao\|Wang, Xiangyu\|Zhou, Zhiyang\|Liu, Gang\|Gao, Shi\|Zhu, Lei
PMID:	27862961

248.
Journal:	Oncotarget. 2017 Jun 6;8(23):37835-37844.
Title:	Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.
Author:	Ofuji, Kazuya\|Saito, Keigo\|Suzuki, Shiro\|Shimomura, Manami\|Shirakawa, Hirofumi\|Nobuoka, Daisuke\|Sawada, Yu\|Yoshimura, Mayuko\|Tsuchiya, Nobuhiro\|Takahashi, Mari\|Yoshikawa, Toshiaki\|Tada, Yoshitaka\|Konishi, Masaru\|Takahashi, Shinichiro\|Gotohda, Naoto\|Nakamo
PMID:	28035063

249.
Journal:	Cancer Immunol Immunother. 2017 Apr;66(4):475-489.
Title:	Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
Author:	Chen, Cheng\|Li, Kesang\|Jiang, Hua\|Song, Fei\|Gao, Huiping\|Pan, Xiaorong\|Shi, Bizhi\|Bi, Yanyu\|Wang, Huamao\|Wang, Hongyang\|Li, Zonghai
PMID:	28035433

250.
Journal:	J Gastroenterol Hepatol. 2017 Aug;32(8):1503-1511.
Title:	The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.
Author:	Xue, Ran\|Feng, Jiliang\|Meng, Qinghua\|Lv, Fudong\|Zhu, Yueke\|Yu, Hongwei\|Zhang, Shijie\|Song, Chenzhao\|Sun, Lin\|Yue, Zhujun\|Feng, Shuai\|Che, Ruiwen\|Xiang, Qian\|Jing, Xiaodan
PMID:	28087980

251.
Journal:	Oncol Rep. 2017 Mar;37(3):1291-1300.
Title:	Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinoma (Review).
Author:	Montalbano, Mauro\|Georgiadis, Jeremias\|Masterson, Ashlyn L\|McGuire, Joshua T\|Prajapati, Janika\|Shirafkan, Ali\|Rastellini, Cristiana\|Cicalese, Luca
PMID:	28098909

252.
Journal:	Cancer Chemother Pharmacol. 2017 Feb;79(2):421-429.
Title:	Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).
Author:	Abou-Alfa, Ghassan K\|Yen, Chia-Jui\|Hsu, Chih-Hung\|O'Donoghue, Joseph\|Beylergil, Volkan\|Ruan, Shutian\|Pandit-Taskar, Neeta\|Gansukh, Bolorsukh\|Lyashchenko, Serge K\|Ma, Jennifer\|Wan, Peter\|Shao, Yu-Yun\|Lin, Zhong-Zhe\|Frenette, Catherine\|O'Neil, Bert\|Schwartz
PMID:	28120036

253.
Journal:	Genet Mol Res. 2017 Feb 8;16(1). pii: gmr-16-01-gmr.16018947.
Title:	Nested polymerase chain reaction technique for the detection of Gpc3 and Afp mRNA in liver cancer micrometastases.
Author:	Luo, J\|Yang, K\|Wen, Y G
PMID:	28198497

254.
Journal:	Med Sci Monit. 2017 Feb 16;23:850-855.
Title:	Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis.
Author:	Sun, Bin\|Huang, Zhi\|Wang, Bi\|Yu, Yanglong\|Lin, Shihai\|Luo, Lei\|Wang, Yuzhu\|Huang, Zheng
PMID:	28207681

255.
Journal:	Sci Rep. 2017 Mar 9;7:44036.
Title:	Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation.
Author:	Feng, Jiliang\|Wu, Jushan\|Zhu, Ruidong\|Feng, Dezhao\|Yu, Lu\|Zhang, Yan\|Bu, Dayu\|Li, Chenlei\|Zhou, Yuyan\|Si, Lianghao\|Liu, Yuhan\|Liang, Ziwei\|Xu, Jianing\|Wu, Tianjun
PMID:	28276470

256.
Journal:	J Fluoresc. 2017 Jul;27(4):1479-1485.
Title:	Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.
Author:	Chen, Juan-Juan\|Xie, Chun-Mei\|Wang, Cong-Rong\|Wan, Yong\|Dong, Zhi-Ning\|Li, Ming\|Xu, Wei-Wen
PMID:	28429175

257.
Journal:	Oncotarget. 2017 Apr 11;8(15):24785-24796.
Title:	Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector.
Author:	Liu, Quan\|Yang, Yijun\|Tan, Xuefang\|Tao, Zhu\|Adah, Dickson\|Yu, Songlin\|Lu, Junnan\|Zhao, Siting\|Qin, Limei\|Qin, Li\|Chen, Xiaoping
PMID:	28445973

258.
Journal:	Discov Med. 2017 Mar;23(126):163-168.
Title:	Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
Author:	Shu, Hong\|Li, Wei\|Shang, Shuxin\|Qin, Xue\|Zhang, Shu\|Liu, Yinkun
PMID:	28472609

259.
Journal:	Oncotarget. 2017 Jun 20;8(25):41211-41226.
Title:	New tumor suppressor microRNAs target glypican-3 in human liver cancer.
Author:	Cartier, Flora\|Indersie, Emilie\|Lesjean, Sarah\|Charpentier, Justine\|Hooks, Katarzyna B\|Ghousein, Amani\|Desplat, Angelique\|Dugot-Senant, Nathalie\|Trezeguet, Veronique\|Sagliocco, Francis\|Hagedorn, Martin\|Grosset, Christophe F
PMID:	28476031

260.
Journal:	Clin Transl Med. 2017 Dec;6(1):18.
Title:	Can glypican-3 be a disease-specific biomarker?
Author:	Chen, Chaolei\|Huang, Xiaomin\|Ying, Zhaojian\|Wu, Dengmin\|Yu, Yani\|Wang, Xiangdong\|Chen, Chengshui
PMID:	28510121

261.
Journal:	Asian Pac J Cancer Prev. 2017 Apr 1;18(4):863-872.
Title:	Hepatocellular Carcinoma: a Comprehensive Review of Biomarkers, Clinical Aspects, and Therapy
Author:	Tunissiolli, Nathalia Martines\|Castanhole-Nunes, Marcia Maria Urbanin\|Biselli-Chicote, Patricia Matos\|Pavarino, Erika Cristina\|da Silva, Renato Ferreira\|da Silva, Rita de Cassia Martins Alves\|Goloni-Bertollo, Eny Maria
PMID:	28545181

262.
Journal:	Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):435-439.
Title:	[A bioinformatics analysis of differentially expressed genes associated with liver cancer].
Author:	Bai, W X\|Gao, J\|Qian, C\|Zhang, X Q
PMID:	28763861

263.
Journal:	Sci China Life Sci. 2017 Nov;60(11):1203-1213.
Title:	MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
Author:	Lv, Guishuai\|Tan, Yexiong\|Lv, Hongwei\|Fang, Tian\|Wang, Changzheng\|Li, Ting\|Yu, Yanting\|Hu, Congli\|Wen, Wen\|Wang, Hongyang\|Yang, Wen
PMID:	28812296

264.
Journal:	Sci Rep. 2017 Aug 29;7(1):9608.
Title:	Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3.
Author:	Xie, Chunmei\|Tiede, Christian\|Zhang, Xuanyi\|Wang, Congrong\|Li, Zhixiong\|Xu, Xiao\|McPherson, Michael J\|Tomlinson, Darren C\|Xu, Weiwen
PMID:	28852111

265.
Journal:	Mol Ther Oncolytics. 2017 Jul 28;6:69-79.
Title:	T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Author:	Szoor, Arpad\|Vaidya, Abishek\|Velasquez, Mireya Paulina\|Mei, Zhuyong\|Galvan, Daniel L\|Torres, David\|Gee, Adrian\|Heczey, Andras\|Gottschalk, Stephen
PMID:	28856237

266.
Journal:	Mol Ther. 2017 Oct 4;25(10):2299-2308.
Title:	A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma.
Author:	Wu, Qunfeng\|Pi, Liya\|Le Trinh, Thu\|Zuo, Chaohui\|Xia, Man\|Jiao, Yu\|Hou, Zhouhua\|Jo, Sung\|Puszyk, William\|Pham, Kien\|Nelson, David R\|Robertson, Keith\|Ostrov, David\|Rameshwar, Pranela\|Xia, Chang Qing\|Liu, Chen
PMID:	28865999

267.
Journal:	Pathol Res Pract. 2017 Sep;213(9):1037-1042.
Title:	Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.
Author:	Luan, Fang\|Liu, Bin\|Zhang, Junguo\|Cheng, Shiqing\|Zhang, Bingchang\|Wang, Yong
PMID:	28869105

268.
Journal:	Oncotarget. 2017 May 16;8(32):52866-52876.
Title:	Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager.
Author:	Bi, Yanyu\|Jiang, Hua\|Wang, Peng\|Song, Bo\|Wang, Huamao\|Kong, Xianming\|Li, Zonghai
PMID:	28881778

269.
Journal:	Cancer Genet. 2017 Oct;216-217:37-51.
Title:	Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Author:	Agarwal, Rahul\|Narayan, Jitendra\|Bhattacharyya, Amitava\|Saraswat, Mayank\|Tomar, Anil Kumar
PMID:	29025594

270.
Journal:	Biomater Sci. 2017 Nov 21;5(12):2468-2479.
Title:	Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.
Author:	Sun, Weitong\|Wang, Yong\|Cai, Mingyue\|Lin, Liteng\|Chen, Xiaoyan\|Cao, Zhong\|Zhu, Kangshun\|Shuai, Xintao
PMID:	29106433

271.
Journal:	Oncotarget. 2017 Jul 6;8(46):80429-80442.
Title:	Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.
Author:	Cheng, Wei\|Huang, Po-Chun\|Chao, Hsiao-Mei\|Jeng, Yung-Ming\|Hsu, Hey-Chi\|Pan, Hung-Wei\|Hwu, Wuh-Liang\|Lee, Yu-May
PMID:	29113314

272.
Journal:	Oncoimmunology. 2017 Jul 11;6(10):e1346764.
Title:	Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma.
Author:	Tsuchiya, Nobuhiro\|Yoshikawa, Toshiaki\|Fujinami, Norihiro\|Saito, Keigo\|Mizuno, Shoichi\|Sawada, Yu\|Endo, Itaru\|Nakatsura, Tetsuya
PMID:	29123959

273.
Journal:	Proteomes. 2017 Nov 23;5(4). pii: proteomes5040033.
Title:	Variety and Dynamics of Proteoforms in the Human Proteome: Aspects of Markers for Hepatocellular Carcinoma.
Author:	Naryzhny, Stanislav\|Zgoda, Victor\|Kopylov, Artur\|Petrenko, Elena\|Kleist, Olga\|Archakov, capital A, Cyrilliclexander
PMID:	29168748

274.
Journal:	Asian Pac J Trop Med. 2017 Nov;10(11):1084-1089.
Title:	*Glypican-3-specific cytotoxic T lymphocytes induced by human leucocyte antigen-A0201-restricted peptide effectively kill hepatocellular carcinoma cells in vitro.**
Author:	Zeng, Jiang-Zheng\|Liu, Yu\|Huang, Fen\|He, Zhi-Hui\|Sun, Huamao\|Lu, Yan-Da\|Lei, Jun-Hua\|Luo, Rong-Cheng
PMID:	29203107

275.
Journal:	Clin Lab. 2017 Nov 1;63(11):1903-1909.
Title:	The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
Author:	Jing, Ji-Sheng\|Ye, Wei\|Jiang, Ying-Kui\|Ma, Jie\|Zhu, Meng-Qi\|Ma, Jiu-Ming\|Zhou, Hua\|Yu, La-Qing\|Yang, Yong-Feng\|Wang, Shun-Cai
PMID:	29226636

276.
Journal:	Sci Rep. 2017 Dec 19;7(1):17751.
Title:	A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.
Author:	Woodfield, Sarah E\|Shi, Yan\|Patel, Roma H\|Jin, Jingling\|Major, Angela\|Sarabia, Stephen F\|Starosolski, Zbigniew\|Zorman, Barry\|Gupta, Siddharth S\|Chen, Zhenghu\|Ibarra, Aryana M\|Bissig, Karl-Dimiter\|Ghaghada, Ketan B\|Sumazin, Pavel\|Lopez-Terrada, Dolores\|Vas
PMID:	29259231

277.
Journal:	Egypt J Immunol. 2017 Jun;24(2):187-200.
Title:	Glypican-3 and Melanoma Antigen Genes 1 and 3 as Tumor Markers for Hepatocellular Carcinoma.
Author:	El-Wahab, Nadia M\|Rashed, Hebat-Allah G\|El-Sherif, Wafaa T\|Sayed, Sohair K\|Abd-Elmalek, Mohamed O\|Refaiy, Abeer\|Fakhry, Hussein\|Mokhtar, Abeer A
PMID:	29708315

278.
Journal:	Med Res Rev. 2018 Mar;38(2):741-767.
Title:	Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
Author:	Zhou, Fubo\|Shang, Wenting\|Yu, Xiaoling\|Tian, Jie
PMID:	28621802

279.
Journal:	Histopathology. 2018 Feb;72(3):414-422.
Title:	From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
Author:	Vasuri, Francesco\|Malvi, Deborah\|Bonora, Sonia\|Fittipaldi, Silvia\|Renzulli, Matteo\|Tovoli, Francesco\|Golfieri, Rita\|Bolondi, Luigi\|D'Errico, Antonia
PMID:	28881044

280.
Journal:	Amino Acids. 2018 Feb;50(2):309-320.
Title:	Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Author:	Wang, Zhen\|Han, Yan-Jiang\|Huang, Shun\|Wang, Meng\|Zhou, Wen-Lan\|Li, Hong-Sheng\|Wang, Quan-Shi\|Wu, Hu-Bing
PMID:	29204748

281.
Journal:	Cell Oncol (Dordr). 2018 Apr;41(2):169-184.
Title:	Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.
Author:	Montalbano, Mauro\|Rastellini, Cristiana\|McGuire, Joshua T\|Prajapati, Janika\|Shirafkan, Ali\|Vento, Renza\|Cicalese, Luca
PMID:	29204978

282.
Journal:	Gut Liver. 2018 May 15;12(3):306-315.
Title:	Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays.
Author:	Hass, Holger G\|Vogel, Ulrich\|Scheurlen, Michael\|Jobst, Jurgen
PMID:	29271183

283.
Journal:	Biochemistry. 2018 Feb 20;57(7):1201-1211.
Title:	Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells.
Author:	Saad, Ahmad\|Liet, Benjamin\|Joucla, Gilles\|Santarelli, Xavier\|Charpentier, Justine\|Claverol, Stephane\|Grosset, Christophe F\|Trezeguet, Veronique
PMID:	29345911

284.
Journal:	Medicine (Baltimore). 2018 Jan;97(4):e9702.
Title:	Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.
Author:	Liu, Hong\|Yang, Chunmei\|Lu, Wenzhu\|Zeng, Yong
PMID:	29369198

285.
Journal:	Onco Targets Ther. 2018 Jan 4;11:193-200.
Title:	Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/beta-catenin signaling.
Author:	Hu, Pei\|Cheng, Bin\|He, Yulin\|Wei, Zhiqiang\|Wu, Dongfang\|Meng, Zhongji
PMID:	29379301

286.
Journal:	Br J Clin Pharmacol. 2018 May;84(5):944-951.
Title:	Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.
Author:	Nakamura, Mikiko\|Xu, Chao\|Diack, Cheikh\|Ohishi, Norihisa\|Lee, Ruey-Min\|Iida, Satofumi\|Kawanishi, Takehiko\|Ohtomo, Toshihiko\|Abou-Alfa, Ghassan K\|Chen, Ya-Chi
PMID:	29381229

287.
Journal:	World J Gastroenterol. 2018 Jan 21;24(3):371-378.
Title:	Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma.
Author:	Xie, Hui\|Xue, Yao-Qin\|Liu, Peng\|Zhang, Peng-Jun\|Tian, Sheng-Tao\|Yang, Zhao\|Guo, Zhi\|Wang, Hua-Ming
PMID:	29391759

288.
Journal:	BMB Rep. 2018 Feb;51(2):57-58.
Title:	SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.
Author:	Shen, Qingyu\|Nam, Suk Woo
PMID:	29397868

289.
Journal:	World J Gastroenterol. 2018 Jan 28;24(4):494-503.
Title:	Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
Author:	Li, You-Cai\|Yang, Chuan-Sheng\|Zhou, Wen-Lan\|Li, Hong-Sheng\|Han, Yan-Jiang\|Wang, Quan-Shi\|Wu, Hu-Bing
PMID:	29398870

290.
Journal:	Chemistry. 2018 May 11;24(27):7060-7067.
Title:	Dual-Selective and Dual-Enhanced SERS Nanoprobes Strategy for Circulating Hepatocellular Carcinoma Cells Detection.
Author:	Pang, Yuanfeng\|Wang, Chongwen\|Xiao, Rui\|Sun, Zhiwei
PMID:	29521467

291.
Journal:	Oncotarget. 2018 Jan 2;9(12):10436-10444.
Title:	Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab.
Author:	Chen, Gong\|Chen, Ya-Chi\|Reis, Bernhard\|Belousov, Anton\|Jukofsky, Lori\|Rossin, Christine\|Muehlig, Axel\|Xu, Chao\|Essioux, Laurent\|Ohtomo, Toshihiko\|Di Laurenzio, Laura\|Puig, Oscar\|Lee, Ray
PMID:	29535817

292.
Journal:	Prep Biochem Biotechnol. 2018 May 28;48(5):435-445.
Title:	Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinoma.
Author:	Wang, Shenghao\|Kalim, Muhammad\|Liang, Keying\|Zhan, Jinbiao
PMID:	29561231

293.
Journal:	Gene Ther. 2018 Apr;25(2):115-128.
Title:	Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma.
Author:	Dhungel, Bijay\|Andrzejewski, Slawomir\|Jayachandran, Aparna\|Shrestha, Ritu\|Ramlogan-Steel, Charmaine A\|Layton, Christopher J\|Steel, Jason C
PMID:	29563582

294.
Journal:	Eur J Histochem. 2018 Jan 29;62(1):2859.
Title:	Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity.
Author:	Moudi, Bita\|Heidari, Zahra\|Mahmoudzadeh-Sagheb, Hamidreza\|Alavian, Seyed-Moayed\|Lankarani, Kamran B\|Farrokh, Parisa\|Randel Nyengaard, Jens
PMID:	29569872

295.
Journal:	J Gastrointest Cancer. 2018 Apr 6. pii: 10.1007/s12029-018-0095-2.
Title:	Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.
Author:	Tahon, Ahmed M\|El-Ghanam, Magdy Z\|Zaky, Samy\|Emran, Tarek Mostafa\|Bersy, Ali M\|El-Raey, Fathiya\|A Z, Elsayed\|El Kharsawy, Amr M\|Johar, Dina
PMID:	29623600

296.
Journal:	Quant Imaging Med Surg. 2018 Mar;8(2):151-160.
Title:	In vivo fluorescence imaging of hepatocellular carcinoma using a novel GPC3-specific aptamer probe.
Author:	Zhao, Menglong\|Dong, Lili\|Liu, Zhuang\|Yang, Shuohui\|Wu, Weizhong\|Lin, Jiang
PMID:	29675356

297.
Journal:	Histopathology. 2018 Oct;73(4):601-611.
Title:	Phenotypic and molecular changes in nodule-in-nodule hepatocellular carcinoma with pathogenetic implications.
Author:	Rudini, Noemi\|Novello, Chiara\|Destro, Annarita\|Riboldi, Elena\|Donadon, Matteo\|Vigano, Luca\|Morenghi, Emanuela\|Roncalli, Massimo\|Di Tommaso, Luca
PMID:	29791027

298.
Journal:	PLoS One. 2018 Jun 7;13(6):e0198552.
Title:	Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
Author:	Wang, Xinmei\|Kwak, Kwang Joo\|Yang, Zhaogang\|Zhang, Aili\|Zhang, Xiaoli\|Sullivan, Rachael\|Lin, Dan\|Lee, Robert L\|Castro, Carlos\|Ghoshal, Kalpana\|Schmidt, Carl\|Lee, L James
PMID:	29879168

299.
Journal:	Medicine (Baltimore). 2018 Jun;97(24):e11130.
Title:	Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
Author:	Zhang, Jian\|Zhang, Manka\|Ma, Huimin\|Song, Xincheng\|He, Lingling\|Ye, Xiaohui\|Li, Xin
PMID:	29901640

300.
Journal:	Drug Deliv. 2018 Nov;25(1):1484-1494.
Title:	Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
Author:	Tang, Xiaolong\|Chen, Longzhou\|Li, Amin\|Cai, Shiyu\|Zhang, Yinci\|Liu, Xueke\|Jiang, Zhenyou\|Liu, Xinkuang\|Liang, Yong\|Ma, Dong
PMID:	29916268

301.
Journal:	Am J Pathol. 2018 Sep;188(9):1973-1981.
Title:	Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database.
Author:	Moek, Kirsten L\|Fehrmann, Rudolf S N\|van der Vegt, Bert\|de Vries, Elisabeth G E\|de Groot, Derk J A
PMID:	29935166

302.
Journal:	Oncol Lett. 2018 Jul;16(1):970-976.
Title:	Elevated GPC3 level promotes cell proliferation in liver cancer.
Author:	Wang, Shanshan\|Chen, Ning\|Chen, Yuhan\|Sun, Lin\|Li, Li\|Liu, Hui
PMID:	29963171

303.
Journal:	Dig Liver Dis. 2018 Jun 21. pii: S1590-8658(18)30799-0.
Title:	Both glypican-3/Wnt/beta-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
Author:	Hu, Pei\|Ke, Changzheng\|Guo, Xingrong\|Ren, Pan\|Tong, Yaoyao\|Luo, Sen\|He, Yulin\|Wei, Zhiqiang\|Cheng, Bin\|Li, Ruiming\|Luo, Jie\|Meng, Zhongji
PMID:	30001951

304.
Journal:	Am J Transl Res. 2018 Jun 15;10(6):1736-1749. eCollection 2018.
Title:	Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model.
Author:	Chen, Kun\|Wu, Zhiyuan\|Zang, Mengya\|Wang, Ce\|Wang, Yanmei\|Wang, Dongmei\|Ma, Yifan\|Qu, Chunfeng
PMID:	30018715

305.
Journal:	Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:395-403.
Title:	Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.
Author:	Gan, Huaiyong\|Chen, Longzhou\|Sui, Xuemei\|Wu, Binquan\|Zou, Shoupin\|Li, Amin\|Zhang, Yinci\|Liu, Xueke\|Wang, Danli\|Cai, Shuyu\|Liu, Xinkuang\|Liang, Yong\|Tang, Xiaolong
PMID:	30033270

306.
Journal:	J Vis Exp. 2018 Jul 12;(137).
Title:	A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity.
Author:	Wang, Yanlan\|Liu, Jiayu\|Pan, Haitao\|Xing, Jieyu\|Wu, Xiaoqiong\|Li, Qing\|Wang, Zhong
PMID:	30059039

307.
Journal:	Cancer Immunol Immunother. 2018 Aug 4. pii: 10.1007/s00262-018-2221-1.
Title:	Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.
Author:	Pan, Zeyan\|Di, Shengmeng\|Shi, Bizhi\|Jiang, Hua\|Shi, Zhimin\|Liu, Ying\|Wang, Yi\|Luo, Hong\|Yu, Min\|Wu, Xiuqi\|Li, Zonghai
PMID:	30078052

308.
Journal:	Nanomedicine (Lond). 2018 Aug 9.
Title:	Novel GPC3-binding WS2-Ga(3+)-PEG-peptide nanosheets for in vivo bimodal imaging-guided photothermal therapy.
Author:	Song, Xiaodong\|Shang, Wenting\|Peng, Li\|Jiang, Hongmei\|Wang, Kun\|Fang, Chihua\|Tian, Jie
PMID:	30091395

309.
Journal:	Int J Nanomedicine. 2018 Aug 1;13:4433-4443.
Title:	A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
Author:	Zhao, Menglong\|Liu, Zhuang\|Dong, Lili\|Zhou, Hongxin\|Yang, Shuohui\|Wu, Weizhong\|Lin, Jiang
PMID:	30122918

310.
Journal:	Onco Targets Ther. 2018 Aug 10;11:4785-4795.
Title:	Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro.
Author:	Tian, Yuhang\|Liu, Zhao\|Zhang, Lei\|Zhang, Jia\|Han, Xue\|Wang, Qiucheng\|Cheng, Wen
PMID:	30127626

311.
Journal:	Contrast Media Mol Imaging. 2018 Sep 10;2018:9169072.
Title:	Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments.
Author:	Li, Weiyue\|Xiao, Xiang\|Li, Xiaodan\|Xu, Yikai\|Ma, Lichao\|Guo, Liuji\|Yan, Chenggong\|Wu, Yuankui
PMID:	30275801

312.
Journal:	J Pak Med Assoc. 2018 Jul;68(7):1029-1031.
Title:	Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours.
Author:	Majeed, Sadia\|Mushtaq, Sajid\|Azam, Muhammad\|Akhtar, Noreen\|Hussain, Mudassar\|Loya, Asif
PMID:	30317296

313.
Journal:	Front Pharmacol. 2018 Oct 1;9:1118.
Title:	Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma.
Author:	Guo, Xingliang\|Jiang, Hua\|Shi, Bizhi\|Zhou, Min\|Zhang, Honghong\|Shi, Zhimin\|Du, Guoxiu\|Luo, Hong\|Wu, Xiuqi\|Wang, Yi\|Sun, Ruixin\|Li, Zonghai
PMID:	30327605

314.
Journal:	Mol Ther Nucleic Acids. 2018 Sep 27;13:376-386.
Title:	Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging.
Author:	Dong, Lili\|Zhou, Hongxin\|Zhao, Menglong\|Gao, Xinghui\|Liu, Yang\|Liu, Dongli\|Guo, Wei\|Hu, Hongwei\|Xie, Qian\|Fan, Jia\|Lin, Jiang\|Wu, Weizhong
PMID:	30347351

315.
Journal:	Hepatology. 2018 Oct 24.
Title:	Glypican-3 Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma.
Author:	Fu, Ying\|Urban, Daniel J\|Nani, Roger R\|Zhang, Yi-Fan\|Li, Nan\|Fu, Haiying\|Shah, Hamzah\|Gorka, Alexander P\|Guha, Rajarshi\|Chen, Lu\|Hall, Matthew D\|Schnermann, Martin J\|Ho, Mitchell
PMID:	30353932

316.
Journal:	Appl Immunohistochem Mol Morphol. 2018 Oct 31.
Title:	Glypican-3 and Hep Par-1 are Useful Biomarkers in the Cytologic Assessment of Ascites.
Author:	Cabibi, Daniela\|Bisanti, Andrea\|Lanza, Dorotea\|Brucculeri, Vanessa\|Porcasi, Rossana\|Ingrao, Sabrina\|Midiri, Federico\|Picone, Dario\|Giannone, Antonino Giulio
PMID:	30383541